Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001687 | 55.9303 | 25.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 55.9318 | 26.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 55.9318 | 26.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 55.9328 | 25.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 57.9298 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 57.9322 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 59.9258 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 59.9275 | 24.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 59.9284 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 67.9325 | 0.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 70.0613 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 70.0626 | 1.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 70.0639 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9338 | 0.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9340 | 25.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9341 | 0.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9349 | 0.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9351 | 26.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9352 | 7.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9352 | 22.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9352 | 26.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9353 | 23.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 72.9358 | 25.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 75.9422 | 20.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 75.9431 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0351 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0356 | 4.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0356 | 4.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0357 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0358 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0360 | 5.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0365 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0367 | 13.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0368 | 13.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0371 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0372 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0381 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0385 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0392 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.0396 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 77.9377 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 79.0552 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 80.0462 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 80.0466 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 80.0483 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 83.9510 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0411 | 24.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0412 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0415 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0415 | 20.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0415 | 22.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0416 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0417 | 20.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0418 | 21.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0418 | 22.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0418 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0421 | 2.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0428 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0428 | 22.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0429 | 22.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0429 | 23.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0432 | 21.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0432 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.0782 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.9568 | 24.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.9570 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.9570 | 24.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.9579 | 25.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.9580 | 25.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.9585 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 84.9590 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 85.9380 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 85.9384 | 20.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 85.9386 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 85.9395 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 85.9395 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 85.9398 | 20.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 85.9399 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 87.9336 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 87.9340 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 87.9350 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 87.9351 | 24.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 87.9355 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 88.9523 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 90.9450 | 0.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 90.9464 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 90.9465 | 6.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 90.9472 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 90.9474 | 0.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 90.9476 | 28.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0510 | 4.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0515 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0515 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0516 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0517 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0522 | 3.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0524 | 6.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0526 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0527 | 3.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0527 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0527 | 13.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0528 | 3.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0529 | 5.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0531 | 13.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0532 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0541 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0548 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0551 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0552 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0553 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0553 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 91.0565 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 93.0671 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 93.0681 | 13.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 93.0682 | 13.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 93.0693 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 95.0466 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9591 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9594 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9601 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9603 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9605 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9605 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9817 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9821 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9822 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9829 | 1.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9835 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9842 | 17.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 98.9852 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 100.9546 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 100.9559 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 100.9559 | 24.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 101.9506 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 101.9506 | 25.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 101.9507 | 29.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 101.9508 | 25.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 101.9510 | 25.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 102.0439 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 102.0440 | 4.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 102.0442 | 4.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 102.0447 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 102.0450 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 102.0452 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0521 | 4.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0526 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0531 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0531 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0533 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0537 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0541 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0547 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 103.0550 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1048 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1050 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1051 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1059 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1060 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1060 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1071 | 7.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1076 | 7.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1078 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1078 | 7.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 104.1080 | 7.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0683 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0684 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0691 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0691 | 13.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0694 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0699 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0700 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0705 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0707 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0708 | 2.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 105.0709 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 108.0434 | 3.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 109.0743 | 3.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 109.0753 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 109.0755 | 3.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 109.0993 | 8.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 109.0994 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 109.1001 | 8.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 109.1002 | 9.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0070 | 1.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0085 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0329 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0357 | 1.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0358 | 1.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0595 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0697 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0700 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 110.0723 | 16.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 111.5128 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.0487 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.0489 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.0492 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.0497 | 1.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.0497 | 2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.0499 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.1107 | 1.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.1109 | 1.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.1110 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 112.1115 | 1.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9459 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9461 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9467 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9468 | 24.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9469 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9620 | 24.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9621 | 25.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9624 | 0.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9627 | 6.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9627 | 8.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9627 | 29.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9628 | 26.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9629 | 6.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9629 | 22.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9629 | 22.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9630 | 0.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9630 | 1.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9630 | 7.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9630 | 25.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9630 | 26.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9631 | 0.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9631 | 0.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9631 | 7.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9631 | 26.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9632 | 6.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 113.9635 | 0.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 114.0899 | 5.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 114.0903 | 6.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 114.0908 | 6.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 114.0910 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.0549 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.0552 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.9622 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.9622 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.9626 | 20.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.9626 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.9629 | 24.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.9631 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 115.9634 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 116.0695 | 1.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 116.0696 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 116.0702 | 1.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 116.0707 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 117.0562 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 117.0578 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 117.9579 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 117.9579 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 117.9583 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 117.9584 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 117.9585 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 117.9586 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0635 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0636 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0638 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0641 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0641 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0642 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0646 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0655 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0833 | 17.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0844 | 8.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0849 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0849 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0850 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0851 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0852 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0853 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0853 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0854 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0857 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0860 | 1.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0861 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0862 | 7.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0862 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0864 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0864 | 7.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0866 | 7.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0868 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0869 | 7.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0869 | 7.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0869 | 7.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0870 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0871 | 7.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0871 | 8.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0872 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0872 | 7.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0872 | 8.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0873 | 7.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 118.0873 | 8.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0342 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0352 | 0.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0354 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0360 | 0.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0361 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0362 | 2.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0478 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0480 | 3.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0484 | 3.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0488 | 3.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0488 | 14.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0489 | 15.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0610 | 1.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0707 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0712 | 5.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0723 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0843 | 13.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0862 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 119.0865 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.0799 | 4.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.0803 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.0806 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.0806 | 5.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.0807 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.0811 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1150 | 4.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1152 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1153 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1155 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1462 | 4.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1462 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1466 | 4.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1470 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1472 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.1472 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.2099 | 4.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.2102 | 4.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.2104 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.2105 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.2108 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.2108 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 120.9831 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 122.0719 | 10.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 122.0722 | 10.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0437 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0439 | 3.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0440 | 3.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0443 | 3.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0538 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0542 | 2.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0543 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0543 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0544 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0546 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0547 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0548 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0549 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0553 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0554 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0556 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0560 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0561 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0562 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.0563 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 123.1220 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0858 | 24.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0859 | 24.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0859 | 24.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0864 | 2.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0864 | 8.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0865 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0866 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0868 | 8.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0869 | 28.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0870 | 0.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0870 | 1.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0870 | 7.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0870 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0870 | 34.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0873 | 2.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0873 | 7.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0873 | 30.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0875 | 28.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0876 | 3.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0877 | 3.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0878 | 9.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0880 | 1.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.0881 | 30.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9632 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9638 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9639 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9640 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9988 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9988 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9993 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9996 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 124.9997 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 125.0001 | 17.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 125.0004 | 17.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 125.0011 | 18.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 126.0358 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 126.0359 | 5.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 126.0367 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 126.0368 | 5.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 126.9618 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 128.0618 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 128.0699 | 3.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 128.0704 | 4.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 129.1372 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 129.1376 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 129.1380 | 1.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 129.1381 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0490 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0490 | 2.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0491 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0494 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0495 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0495 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0496 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0496 | 1.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0496 | 2.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0496 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.0498 | 3.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1577 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1578 | 24.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1582 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1586 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1587 | 6.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1589 | 6.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1591 | 6.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1594 | 2.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1595 | 33.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1597 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1597 | 30.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1598 | 0.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1598 | 2.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1598 | 28.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1598 | 32.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1599 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1599 | 2.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1599 | 3.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1599 | 38.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1599 | 39.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1600 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1600 | 30.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1601 | 26.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1601 | 34.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1602 | 25.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1603 | 36.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1605 | 29.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.1606 | 3.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 130.9335 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1171 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1171 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1176 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1180 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1182 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1183 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1185 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1185 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1185 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1186 | 7.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 131.1186 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0031 | 25.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0031 | 25.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0035 | 25.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0036 | 26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0045 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0760 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0761 | 1.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0762 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0767 | 1.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0769 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0770 | 7.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0771 | 5.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0771 | 7.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0774 | 7.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0775 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0775 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0776 | 7.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0777 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0778 | 8.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 132.0798 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 133.0651 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 135.0297 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 135.0298 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 135.0306 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 135.0798 | 13.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0613 | 3.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0613 | 5.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0614 | 3.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0614 | 3.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0614 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0614 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0615 | 5.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0617 | 1.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0617 | 2.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0617 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0617 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0617 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0618 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0619 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0619 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0619 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0619 | 9.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0619 | 11.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0619 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0620 | 1.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0620 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0620 | 17.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0620 | 19.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0622 | 0.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0622 | 10.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0623 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0623 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0623 | 9.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0623 | 13.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0623 | 15.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0624 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0624 | 9.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0624 | 18.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0625 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0625 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0625 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0625 | 20.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0626 | 20.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0635 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0753 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0754 | 3.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.0758 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.1324 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.1325 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.1328 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.1329 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.1998 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.2007 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.2013 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.9308 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 136.9312 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0452 | 3.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0455 | 3.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0456 | 2.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0456 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0457 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0459 | 2.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0459 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0459 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0460 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0460 | 2.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0460 | 9.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0461 | 11.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0463 | 1.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0463 | 12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0465 | 1.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0465 | 8.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0466 | 9.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0466 | 9.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0467 | 0.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0470 | 0.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0471 | 6.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0786 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0939 | 1.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.0944 | 1.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.1163 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.1164 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.1168 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.1168 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.1852 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.1853 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 137.9646 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.0497 | 2.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.0546 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.0555 | 7.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.0662 | 6.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.0914 | 1.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1267 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1274 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1275 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1277 | 3.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1279 | 3.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1279 | 5.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1279 | 5.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1284 | 3.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 138.1285 | 3.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 139.9874 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 139.9876 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 139.9879 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 139.9880 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0482 | 9.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0483 | 10.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0483 | 11.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0484 | 11.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0485 | 8.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0485 | 10.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0485 | 10.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0650 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0801 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0802 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0803 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0804 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0805 | 5.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.0805 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.1017 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.1019 | 9.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.1022 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.1024 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.1026 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.1026 | 6.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.1028 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 144.1035 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 146.0598 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 146.0599 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 146.0600 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 146.0600 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 146.0602 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 147.0221 | 1.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 147.0439 | 3.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 148.0598 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0228 | 22.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0230 | 22.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0231 | 17.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0232 | 11.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0232 | 12.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0232 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0233 | 11.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0233 | 16.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0233 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0233 | 18.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0235 | 12.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0235 | 18.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0235 | 22.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0235 | 23.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0236 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0237 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0237 | 12.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0237 | 18.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0237 | 23.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0238 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0238 | 13.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0238 | 18.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0240 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0455 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 149.0610 | 15.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 150.0469 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0366 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0375 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0379 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0380 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0380 | 7.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0380 | 7.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0381 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0382 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0382 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0382 | 7.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0564 | 9.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0566 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0568 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0568 | 9.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0570 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0570 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0570 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0570 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0570 | 2.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0570 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0571 | 2.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0572 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0572 | 2.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0573 | 2.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0575 | 2.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0576 | 10.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0622 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0624 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0624 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0625 | 1.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0626 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0627 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.0719 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 152.1422 | 9.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 153.0692 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 153.0695 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 153.4896 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 156.0775 | 10.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 156.1021 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 157.1334 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 157.1339 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 157.1339 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 157.1339 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 157.1341 | 7.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 157.1341 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 157.1342 | 7.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 157.1343 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 158.1544 | 12.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 158.1544 | 13.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 159.0280 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 159.0281 | 2.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 159.0910 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 159.0913 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 159.0913 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 159.0917 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 159.0919 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 159.0921 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.0587 | 3.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.0588 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.0589 | 4.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.0589 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1121 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1126 | 1.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1127 | 11.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1129 | 8.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1129 | 10.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1129 | 10.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1130 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1130 | 10.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1131 | 9.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1131 | 9.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1131 | 10.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1131 | 10.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1131 | 10.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1132 | 7.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1273 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 162.1280 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 163.1472 | 11.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 163.1479 | 23.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 163.1483 | 11.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 163.1485 | 11.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 163.9701 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.0376 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.0377 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.0381 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.0383 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.0386 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.1280 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.1286 | 6.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.1286 | 6.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.1296 | 6.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9203 | 5.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9207 | 8.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9208 | 7.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9208 | 8.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9209 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9210 | 7.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9211 | 7.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9211 | 9.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9215 | 5.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9219 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9219 | 10.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 164.9221 | 5.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 165.0552 | 3.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 165.9911 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 165.9913 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 165.9914 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 165.9915 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 165.9917 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 165.9917 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 166.0538 | 7.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 166.0865 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 166.0865 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 166.0868 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 166.0871 | 4.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 166.0872 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 166.1574 | 10.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1541 | 32.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1542 | 2.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1543 | 33.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1545 | 34.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1546 | 38.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1547 | 1.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1547 | 35.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1548 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1550 | 35.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.1553 | 31.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.9870 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 167.9874 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 168.0572 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 168.0576 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 168.0645 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 168.0652 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 168.0652 | 2.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 168.0656 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 169.0611 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 169.0613 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 169.0614 | 2.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 169.0616 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 169.9863 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 170.1182 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 170.1547 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 171.0109 | 7.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 171.0445 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.0950 | 5.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.1701 | 12.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.1701 | 13.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.1704 | 12.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.1704 | 13.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.1704 | 13.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.1706 | 12.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8827 | 20.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8827 | 31.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8832 | 36.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8833 | 0.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8833 | 28.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8833 | 31.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8833 | 37.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8834 | 29.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8834 | 32.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8834 | 32.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8834 | 35.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8835 | 21.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8835 | 29.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8835 | 30.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8836 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8836 | 20.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8836 | 22.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8836 | 27.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8836 | 31.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8836 | 34.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8837 | 1.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8837 | 2.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8837 | 39.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 0.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 5.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 25.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 28.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 29.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 32.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 38.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8838 | 39.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8839 | 0.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8839 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8839 | 5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8839 | 24.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8839 | 26.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8839 | 30.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8839 | 35.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8840 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8840 | 26.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8840 | 30.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8840 | 32.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8841 | 25.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8841 | 35.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8841 | 36.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8841 | 38.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8841 | 39.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8842 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8842 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8842 | 25.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8842 | 26.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8842 | 27.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8843 | 36.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 172.8844 | 24.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0783 | 38.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0785 | 32.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0786 | 36.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0787 | 2.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0787 | 4.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0787 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0787 | 35.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0787 | 39.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0788 | 28.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0788 | 35.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0789 | 0.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0789 | 1.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0789 | 30.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0790 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0790 | 4.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0790 | 29.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0790 | 30.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0790 | 35.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0790 | 38.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0791 | 33.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0791 | 39.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0791 | 39.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0792 | 0.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0792 | 34.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0792 | 39.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0794 | 3.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.0797 | 38.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 173.1331 | 11.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 174.0346 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 175.1190 | 13.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 175.1190 | 13.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 175.1191 | 12.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 175.1192 | 13.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 175.1193 | 13.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 175.1195 | 13.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 175.1488 | 12.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 175.1490 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 176.0658 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 176.0659 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 176.0660 | 5.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 176.0660 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 176.0661 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 176.0662 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 176.0742 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 176.0746 | 5.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 179.0353 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 179.0355 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 179.0356 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 179.0358 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 179.8692 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 180.1752 | 10.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 180.9041 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 181.0099 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 181.0102 | 0.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 181.0332 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 181.0339 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 181.0339 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 181.9621 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1900 | 1.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1904 | 2.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1907 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1907 | 2.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1908 | 0.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1908 | 2.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1909 | 2.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1909 | 2.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1910 | 8.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1910 | 8.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1911 | 8.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1912 | 3.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1912 | 7.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1915 | 7.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.1915 | 7.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.2735 | 7.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.9619 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 182.9620 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 183.9895 | 11.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0730 | 11.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0730 | 13.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0734 | 24.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0735 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0735 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0735 | 14.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0736 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0736 | 12.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0736 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0736 | 25.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 11.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 12.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 12.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 14.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 16.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 17.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 20.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0737 | 25.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0738 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0738 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0738 | 6.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0738 | 12.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0738 | 18.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0738 | 20.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0738 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0739 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0739 | 13.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0739 | 13.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0739 | 14.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0739 | 17.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0739 | 17.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0739 | 17.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0739 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 6.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 13.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 14.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 15.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 17.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 21.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 22.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0740 | 24.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 12.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 14.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 14.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 15.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0741 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 13.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 14.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 16.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 16.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 21.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0742 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0743 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0743 | 14.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0743 | 15.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0743 | 16.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0743 | 16.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0743 | 16.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0745 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0745 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0745 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0746 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0746 | 15.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0748 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.0752 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1176 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1176 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1177 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1179 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1180 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1181 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1298 | 17.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1561 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1562 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1563 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1566 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1566 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1566 | 16.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1566 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.1695 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.2357 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.2361 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.2361 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.2362 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.2363 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.4468 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.4469 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.4474 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 184.9668 | 18.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 185.0782 | 15.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 185.1153 | 8.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 185.9413 | 0.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 185.9415 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 185.9419 | 3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 185.9420 | 6.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 186.0767 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 186.0769 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 186.0770 | 2.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 186.9242 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 187.1074 | 6.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 187.1081 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.0553 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.0715 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.0716 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.0719 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.1544 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.1545 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.1551 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.2347 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.2347 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.8971 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 188.9206 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 191.0769 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 191.0777 | 1.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0564 | 7.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0565 | 5.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0565 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0565 | 7.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0565 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0566 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0567 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0567 | 7.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 192.0570 | 7.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 193.1595 | 12.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 193.9307 | 1.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1167 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1172 | 5.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1176 | 9.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1177 | 9.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1177 | 9.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1177 | 10.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1178 | 9.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1179 | 8.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1179 | 9.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1180 | 9.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.1189 | 7.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 194.9072 | 29.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0799 | 7.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0800 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0800 | 7.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0800 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0800 | 7.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0802 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0803 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0904 | 6.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0920 | 7.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.0922 | 1.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.1722 | 6.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.2560 | 6.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.9126 | 25.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.9126 | 26.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.9127 | 26.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.9778 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.9779 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 195.9782 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 196.1704 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 196.1706 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 196.1708 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 196.8788 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 197.0804 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 197.1150 | 7.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 197.1154 | 6.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 197.1155 | 7.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 197.1157 | 6.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 198.1856 | 14.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 198.1858 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 198.9396 | 30.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 198.9397 | 30.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 198.9403 | 29.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 198.9403 | 30.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 198.9411 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 200.2019 | 16.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 200.9121 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 200.9123 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 200.9126 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 200.9127 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 201.9343 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 201.9344 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 201.9348 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 202.0714 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 202.1223 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 202.1799 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 203.1794 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 203.1801 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 203.1802 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 203.2233 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 203.2239 | 1.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 203.2241 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 203.2242 | 1.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.0448 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.0875 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.0876 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1062 | 8.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1230 | 10.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1230 | 10.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1233 | 6.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1234 | 9.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1234 | 10.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1235 | 9.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1235 | 9.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1235 | 9.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1236 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1236 | 7.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1236 | 9.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1237 | 2.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1238 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1239 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1240 | 9.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1241 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1241 | 2.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1242 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1242 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1243 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1454 | 9.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1824 | 9.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.1825 | 9.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.8712 | 1.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 204.8715 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 205.0800 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 205.0824 | 1.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 205.9615 | 5.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 205.9616 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 205.9617 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 206.0545 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 206.0551 | 21.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 206.0552 | 18.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 206.0553 | 19.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 206.0562 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 206.0564 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 206.0566 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 207.0059 | 11.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 207.0313 | 2.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 207.0323 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 207.0324 | 12.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 207.0327 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 207.1015 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 208.9732 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 208.9737 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 208.9737 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 208.9738 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 209.0093 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 209.0099 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 209.0115 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 209.0118 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 209.1183 | 13.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 210.0507 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 210.1115 | 7.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.1190 | 1.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.1196 | 7.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.1437 | 11.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.1553 | 1.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.1792 | 1.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.2009 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.2015 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.2017 | 10.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.2075 | 7.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.2933 | 7.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.9044 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.9191 | 30.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.9192 | 27.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.9192 | 30.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.9193 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.9195 | 30.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 212.9200 | 26.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 213.0118 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 213.1466 | 12.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0062 | 8.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0063 | 8.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0063 | 9.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0064 | 8.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0064 | 8.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0065 | 8.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0065 | 8.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0066 | 8.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0713 | 2.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0714 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0717 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.0725 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.2518 | 0.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.2527 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.2532 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.2534 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.2538 | 2.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.2539 | 12.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.2544 | 13.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.8513 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9168 | 32.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9169 | 32.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9173 | 12.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9173 | 26.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9177 | 29.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9184 | 24.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9185 | 25.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9187 | 25.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9187 | 25.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9196 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 214.9666 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 215.0074 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 215.0605 | 3.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 215.0943 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 215.1257 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 215.1264 | 6.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 215.1265 | 6.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 215.1266 | 6.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 215.3242 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 216.0152 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 216.0636 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 216.0845 | 1.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1046 | 0.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1049 | 1.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1049 | 1.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1051 | 0.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1051 | 1.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1051 | 1.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1051 | 1.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1051 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1051 | 38.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1051 | 39.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1052 | 0.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1057 | 5.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1058 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1058 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1060 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1060 | 5.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1060 | 5.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1063 | 5.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1948 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1950 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1950 | 4.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 217.1957 | 5.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.1388 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.1388 | 9.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.1389 | 9.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.1391 | 9.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.1392 | 8.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.1534 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.2112 | 9.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.2122 | 9.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.2124 | 8.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.2127 | 8.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.4703 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.9118 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 218.9364 | 34.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.0805 | 5.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.0808 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.0810 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1418 | 9.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1739 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1745 | 2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1746 | 2.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1748 | 2.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1750 | 10.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1751 | 9.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1751 | 10.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1758 | 9.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1758 | 10.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 219.1759 | 10.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 220.1182 | 4.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 221.0188 | 11.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 221.0842 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 221.0845 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 221.0955 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 221.0958 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 221.0964 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 221.1180 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 222.0303 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 222.0305 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 222.0309 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 222.1469 | 10.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 222.1470 | 10.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 222.9895 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.0634 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.0639 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.0639 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.0639 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.0640 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.0648 | 12.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.0650 | 12.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.2057 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 223.9899 | 1.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 224.1282 | 9.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 224.1286 | 9.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 225.0428 | 2.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 225.0432 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 225.0434 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 225.0455 | 12.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.0449 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.0449 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.0450 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.0453 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.0685 | 13.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.2170 | 23.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.2173 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9511 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9513 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9515 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9517 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9517 | 5.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9517 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9517 | 5.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9518 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9520 | 5.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9527 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9528 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9529 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9531 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9531 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9531 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 226.9536 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 227.0276 | 12.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 227.1265 | 11.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 227.1269 | 11.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 228.0933 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 228.0936 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 229.0998 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 229.1011 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 229.1417 | 8.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 229.9805 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.0916 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.1409 | 34.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.1534 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.2479 | 13.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.2483 | 13.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.2485 | 12.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.2487 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.2490 | 11.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.2493 | 11.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 230.8902 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.0448 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.0836 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.0922 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.0971 | 7.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1201 | 2.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1205 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1206 | 1.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1207 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1209 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1210 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1212 | 5.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1212 | 6.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1213 | 5.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1213 | 5.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.1217 | 6.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.9398 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.9895 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 231.9895 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.0749 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.0825 | 2.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.0836 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.1231 | 1.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.1545 | 8.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.1546 | 8.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.1547 | 8.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.1547 | 8.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 232.1547 | 8.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 233.0364 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 233.0368 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 233.0600 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 233.0783 | 9.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 234.9011 | 30.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 234.9015 | 30.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 235.1466 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 235.2377 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 235.3286 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 236.1638 | 11.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 236.1640 | 11.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0900 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0902 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0903 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0903 | 7.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0905 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0905 | 7.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0909 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0912 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0914 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0916 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 237.0919 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 238.0448 | 8.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 238.1329 | 12.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 238.1440 | 9.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 238.8854 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.0899 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.0902 | 8.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1066 | 14.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1080 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1085 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1089 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1443 | 7.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1445 | 7.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1445 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1447 | 7.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1448 | 7.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1448 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1449 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1483 | 36.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1484 | 35.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1487 | 33.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1488 | 30.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1490 | 36.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1574 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1703 | 5.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1704 | 7.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1705 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1706 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.1996 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2005 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2005 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2006 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2006 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2009 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2091 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2098 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2100 | 5.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2101 | 7.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2103 | 7.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2106 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2115 | 7.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2384 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2386 | 7.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2488 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2686 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2924 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2928 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2928 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2928 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2929 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.2929 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.3560 | 7.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.3562 | 7.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.3563 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.3569 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.4207 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.4207 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.4864 | 7.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.4887 | 7.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.4888 | 7.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.5339 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.5348 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.5355 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.5365 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.5367 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.5368 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 239.9211 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.0993 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.0993 | 17.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.1003 | 16.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.1004 | 15.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.1004 | 17.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.1375 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.1400 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2312 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2325 | 12.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2325 | 12.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2325 | 23.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2326 | 12.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2329 | 23.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2331 | 22.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2332 | 12.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2337 | 11.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2684 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.2688 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.3270 | 11.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.4184 | 11.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 240.8829 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 241.0319 | 1.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 241.0319 | 1.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 241.0320 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 241.0320 | 1.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 241.1036 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 241.1039 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 241.1054 | 7.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 241.1416 | 12.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 242.0013 | 8.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 242.0998 | 4.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 242.0999 | 4.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 242.1013 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 242.6414 | 19.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 242.9135 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 242.9266 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.0884 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.0885 | 8.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.0887 | 8.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.1200 | 2.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.1223 | 6.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.1364 | 16.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.1831 | 30.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.6837 | 29.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 243.9456 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.0122 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.0792 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.0793 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.0793 | 3.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.0794 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.0794 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.0796 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.2637 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.2638 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.2639 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.2643 | 13.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.2643 | 13.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.2646 | 12.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.2647 | 12.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 244.2648 | 13.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.0774 | 10.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.0995 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1056 | 10.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1129 | 11.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1136 | 11.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1353 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1359 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1361 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1362 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1370 | 7.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1370 | 7.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1371 | 6.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1373 | 6.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1375 | 7.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 245.1376 | 6.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.0760 | 10.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1540 | 10.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1698 | 8.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1699 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1700 | 8.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1703 | 8.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1704 | 7.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1705 | 8.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1705 | 8.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1708 | 6.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1709 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1709 | 6.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1710 | 6.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.1711 | 6.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.2428 | 10.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.2438 | 11.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.2439 | 11.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.2440 | 10.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 246.2442 | 10.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 247.0941 | 31.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 248.0599 | 12.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 248.1038 | 6.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 248.1646 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 249.1086 | 1.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 249.1102 | 2.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 249.1120 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0929 | 21.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0930 | 17.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0930 | 20.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0932 | 20.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0933 | 18.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0934 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0934 | 21.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0935 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0941 | 20.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0945 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0945 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0946 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.0953 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1769 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1774 | 21.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1775 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1779 | 21.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1780 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1783 | 20.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1787 | 11.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1788 | 12.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1788 | 21.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1789 | 11.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1789 | 11.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1789 | 12.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.1790 | 12.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 250.8642 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 251.0465 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 251.2369 | 23.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 252.1581 | 10.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.1773 | 12.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.1776 | 12.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.1778 | 12.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.1782 | 12.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.1784 | 13.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.1788 | 13.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.6319 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.6323 | 13.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 253.6324 | 14.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 254.2476 | 23.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 254.2479 | 22.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 254.2479 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 254.2485 | 22.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 254.2491 | 23.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 255.1005 | 8.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 255.1005 | 9.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 255.1010 | 8.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 255.1015 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 255.1015 | 9.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 255.1016 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 255.1021 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2640 | 19.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2640 | 20.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2641 | 20.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2642 | 22.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2644 | 19.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2645 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2645 | 22.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2646 | 21.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 256.2647 | 22.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 257.0991 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 257.1353 | 1.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 257.1361 | 1.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1098 | 7.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1099 | 11.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1100 | 10.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1104 | 11.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1105 | 11.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1107 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1110 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1112 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.1771 | 11.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.2791 | 3.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 258.9576 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.0902 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.0924 | 4.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.1111 | 3.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.1148 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.1472 | 6.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.1526 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.1654 | 5.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.9863 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.9864 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.9866 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 259.9867 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 260.0266 | 8.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 260.0271 | 8.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 260.0753 | 10.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 260.0777 | 1.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 260.0778 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 260.0778 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 260.0778 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 260.6582 | 16.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.0875 | 10.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.0875 | 12.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.0882 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.0889 | 13.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1097 | 11.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1100 | 11.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1124 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1126 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1128 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1140 | 7.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1142 | 6.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1142 | 7.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1142 | 7.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1148 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1308 | 7.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1309 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1310 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1312 | 0.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1312 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1312 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1312 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1312 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1312 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1312 | 3.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1312 | 38.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1320 | 5.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1321 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1322 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1322 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1323 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1323 | 5.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1452 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1548 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1548 | 7.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 261.1551 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0501 | 14.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0504 | 15.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0504 | 17.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0504 | 20.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0506 | 15.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0506 | 17.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0507 | 16.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0507 | 20.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0508 | 17.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0509 | 17.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0510 | 17.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0511 | 17.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0511 | 17.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.0514 | 14.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.1449 | 18.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.2528 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 262.2529 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 263.0517 | 19.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 263.0816 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 263.0817 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 263.0844 | 5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 263.0847 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2679 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2683 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2684 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2686 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2687 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2688 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2689 | 20.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2691 | 19.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 264.2692 | 20.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.1716 | 1.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.2843 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.2845 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.6400 | 14.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.6400 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.6400 | 15.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.6401 | 14.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.6402 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.9991 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 266.9993 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1224 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1224 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1224 | 1.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1225 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1228 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1228 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1232 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1232 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1244 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1266 | 10.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1269 | 10.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1270 | 10.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1563 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.1638 | 13.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.2092 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.6473 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.6474 | 15.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.6476 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.6479 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.6479 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.6481 | 16.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.6481 | 17.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.9672 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.9676 | 1.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 267.9676 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.0266 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1035 | 0.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1036 | 2.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1039 | 1.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1039 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1041 | 3.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1042 | 1.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1042 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1044 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1048 | 3.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1048 | 3.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1049 | 4.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.1050 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.2634 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.2638 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.2645 | 13.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.2648 | 22.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.2997 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.2997 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.3002 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.9784 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 268.9785 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.1001 | 9.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.1003 | 9.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.2086 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.2089 | 16.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.2092 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.2094 | 17.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.2095 | 18.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.2096 | 16.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.2097 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.2265 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.9652 | 5.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.9662 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 269.9663 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.2068 | 6.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.2793 | 21.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.2793 | 23.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.2795 | 20.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.2798 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.2803 | 21.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.3148 | 14.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.3152 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.9779 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 270.9785 | 5.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 271.1509 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 271.1884 | 13.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 271.1891 | 12.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 271.1898 | 13.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 271.2753 | 11.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.2965 | 14.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8849 | 12.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8851 | 20.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8852 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8854 | 21.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8856 | 14.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8856 | 26.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8857 | 28.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8857 | 30.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8858 | 12.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8858 | 21.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8858 | 25.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8858 | 27.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8858 | 30.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8859 | 17.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8859 | 18.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8859 | 21.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8859 | 30.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8860 | 12.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8860 | 17.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8860 | 29.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8863 | 13.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8865 | 20.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 272.8865 | 27.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.0902 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.0909 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.0914 | 12.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.0917 | 12.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.0919 | 13.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.0921 | 12.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.0921 | 13.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1303 | 1.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1669 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1671 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1671 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1673 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1675 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1675 | 8.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1675 | 10.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1676 | 8.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1679 | 8.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1681 | 10.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1683 | 7.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1684 | 9.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1684 | 10.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1685 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 273.1686 | 9.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.0613 | 2.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.0912 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.0915 | 1.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.0924 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.0932 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.0935 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2730 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2736 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2738 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2739 | 28.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2739 | 39.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2740 | 0.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2740 | 2.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2742 | 33.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2742 | 34.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2742 | 37.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2743 | 33.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2743 | 36.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2744 | 36.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2746 | 12.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2748 | 11.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2752 | 12.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2753 | 12.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2755 | 11.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.2755 | 11.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.3746 | 11.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.3750 | 12.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.8732 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.8735 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.8741 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.8746 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.8751 | 1.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.9298 | 19.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.9302 | 18.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.9310 | 20.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.9315 | 19.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 274.9319 | 18.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 275.1092 | 1.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1193 | 1.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1204 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1261 | 7.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1270 | 7.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1271 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1274 | 7.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1280 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1554 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1562 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 276.1603 | 16.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.0591 | 6.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.0614 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.0615 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.0713 | 11.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.0828 | 8.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.0829 | 9.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.0833 | 9.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1014 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1030 | 10.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1031 | 10.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1034 | 10.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1042 | 1.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1044 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1045 | 2.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1048 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1049 | 6.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1050 | 5.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1050 | 6.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1309 | 7.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1419 | 12.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1424 | 13.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1633 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1638 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1638 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1640 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1799 | 14.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.1805 | 18.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.2047 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.2619 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 277.2621 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.0913 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.1750 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9027 | 5.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9027 | 6.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9029 | 0.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9029 | 33.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9030 | 0.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9030 | 5.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9030 | 36.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9030 | 36.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9031 | 31.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9031 | 36.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9031 | 37.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9032 | 0.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9032 | 0.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9032 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9032 | 29.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9032 | 33.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9032 | 35.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9032 | 39.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9032 | 39.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9033 | 0.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9033 | 34.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9033 | 35.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9033 | 35.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9033 | 36.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9033 | 36.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9034 | 33.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9034 | 34.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9034 | 34.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9035 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9035 | 32.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9035 | 39.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9036 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9036 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9036 | 2.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9036 | 31.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 278.9037 | 2.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0587 | 5.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0593 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0594 | 5.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0932 | 12.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0940 | 12.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0942 | 11.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0944 | 12.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0950 | 11.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0954 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0960 | 15.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0964 | 15.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0972 | 14.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0982 | 4.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0983 | 14.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0991 | 5.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.0992 | 14.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.1205 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.1695 | 8.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 279.9037 | 32.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.0618 | 7.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6548 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6549 | 17.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6553 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6555 | 17.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6556 | 16.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6556 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6557 | 17.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6558 | 16.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 280.6560 | 16.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.0505 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.0511 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.0512 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.0514 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.0515 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1010 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1017 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1019 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1026 | 13.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1037 | 12.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1037 | 13.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1373 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1393 | 13.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1716 | 15.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1725 | 15.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1725 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1726 | 16.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.1728 | 16.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.2522 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.3510 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 281.6641 | 18.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2776 | 23.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2783 | 22.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2786 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2788 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2793 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2794 | 14.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2796 | 14.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2796 | 20.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 282.2800 | 22.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0692 | 6.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0696 | 8.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0697 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0697 | 6.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0697 | 6.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0698 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0699 | 7.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0699 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0699 | 7.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0700 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0701 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0702 | 7.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0704 | 7.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0710 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0711 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0712 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0713 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0715 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0954 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.0955 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1742 | 1.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1749 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1750 | 28.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1751 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1751 | 28.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1752 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1753 | 39.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1754 | 0.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1754 | 32.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1755 | 0.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1755 | 32.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1756 | 29.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.1764 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.2248 | 17.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.2248 | 18.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.2257 | 19.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 283.2274 | 12.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.0313 | 18.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.0323 | 19.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.0324 | 18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.0324 | 20.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.0327 | 18.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.0328 | 19.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.0329 | 19.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.0333 | 20.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.1780 | 2.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.1783 | 0.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2950 | 22.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2951 | 21.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2952 | 21.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2953 | 22.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2953 | 22.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2953 | 23.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2954 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2954 | 21.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2954 | 23.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2957 | 21.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2958 | 23.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.2960 | 23.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 284.8700 | 7.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 285.0096 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 285.0100 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 285.2431 | 14.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 285.2431 | 14.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 285.2434 | 13.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 285.2440 | 13.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 285.2918 | 11.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 286.0964 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 286.0967 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 286.0970 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 286.0970 | 13.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 286.0975 | 12.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 286.1612 | 2.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 287.2365 | 16.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 287.2379 | 15.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.1745 | 20.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.1747 | 20.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2894 | 1.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2895 | 1.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2896 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2898 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2898 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2898 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2899 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2900 | 13.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2901 | 13.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2902 | 12.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2903 | 12.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2903 | 13.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2903 | 13.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2904 | 12.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2904 | 12.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2905 | 12.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.2908 | 12.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 288.9218 | 5.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 289.1617 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 290.6396 | 15.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 290.6402 | 15.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 290.6410 | 14.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 290.8456 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 290.8479 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.0698 | 2.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.0700 | 2.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.0710 | 2.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.2678 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.6473 | 15.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.6477 | 15.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.6477 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.6478 | 15.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.6480 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.6480 | 16.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.6481 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 291.6489 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 292.1034 | 1.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 292.1917 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 292.6555 | 15.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 292.6556 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 292.6564 | 16.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1080 | 37.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1082 | 29.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1083 | 36.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1084 | 33.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1085 | 0.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1085 | 35.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1086 | 1.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1086 | 2.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1086 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1086 | 36.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1087 | 2.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1087 | 36.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1088 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1088 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1088 | 33.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1088 | 36.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1089 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1089 | 2.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1089 | 37.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1089 | 38.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1089 | 38.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1090 | 27.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1090 | 33.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1091 | 0.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1091 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1091 | 38.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1092 | 0.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1092 | 3.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1092 | 31.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1093 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1093 | 30.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1093 | 36.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1093 | 37.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1093 | 38.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1093 | 39.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1094 | 0.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1094 | 38.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1095 | 30.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1097 | 39.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1102 | 38.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1588 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1601 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1602 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1603 | 1.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1783 | 24.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1786 | 25.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1790 | 24.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1790 | 25.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.1795 | 24.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.2832 | 22.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 293.2948 | 1.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 294.1111 | 36.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 294.3147 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 294.8677 | 29.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 294.9386 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 294.9393 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 294.9394 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 295.0652 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 295.1301 | 6.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 295.1376 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 295.1405 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 295.1916 | 13.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 295.1929 | 16.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 295.1936 | 25.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 295.1951 | 15.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 296.0666 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 296.0671 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 296.2563 | 12.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 296.2946 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 296.8709 | 3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.0396 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.0401 | 2.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.0816 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.0831 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.1587 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.1592 | 7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.1597 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.2400 | 20.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.2402 | 19.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.2406 | 19.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.2407 | 20.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.2410 | 18.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.2414 | 18.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6151 | 28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6155 | 8.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6160 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6161 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6162 | 8.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6165 | 8.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6170 | 2.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6174 | 3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 297.6180 | 4.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0532 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0537 | 1.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0965 | 1.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0965 | 1.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0965 | 2.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0966 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0968 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0968 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0969 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0970 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0970 | 1.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0971 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0977 | 5.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0978 | 5.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0982 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.0983 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.1005 | 9.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.2642 | 21.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.3466 | 1.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.3466 | 16.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 298.3468 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0424 | 8.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0426 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0436 | 7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0437 | 7.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0438 | 7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0440 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0442 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0450 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0614 | 2.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0630 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0631 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.0847 | 10.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1104 | 10.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1109 | 10.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1110 | 11.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1112 | 11.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1601 | 18.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1611 | 17.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1614 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1635 | 16.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 299.1635 | 18.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.1207 | 9.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.1208 | 2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.1210 | 9.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.1211 | 9.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.1214 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.1986 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.2897 | 20.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8842 | 31.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8846 | 5.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8846 | 30.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8848 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8848 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8848 | 32.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8848 | 33.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8849 | 0.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8849 | 34.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8849 | 35.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8849 | 35.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8849 | 39.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8850 | 0.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8850 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8850 | 5.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8850 | 5.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8850 | 38.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8851 | 0.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8851 | 2.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8851 | 31.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8852 | 0.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8852 | 1.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8852 | 2.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8852 | 3.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8852 | 39.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8853 | 0.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8853 | 0.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8853 | 5.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8853 | 35.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8853 | 39.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8854 | 0.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8854 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8854 | 33.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8855 | 29.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8855 | 36.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8855 | 37.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8855 | 39.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8858 | 3.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 300.8859 | 35.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0739 | 26.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0741 | 3.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0748 | 27.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0748 | 35.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0750 | 12.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0750 | 31.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0750 | 31.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0750 | 39.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0751 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0751 | 31.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0752 | 33.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0753 | 0.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0753 | 34.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0753 | 39.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0754 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0754 | 27.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0754 | 30.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0754 | 32.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0754 | 34.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0755 | 26.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0755 | 35.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0755 | 36.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0756 | 29.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0757 | 31.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0757 | 33.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0757 | 37.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0758 | 29.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0758 | 35.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0759 | 33.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0759 | 39.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0761 | 26.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0761 | 31.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.0762 | 30.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.1404 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.1418 | 18.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.1421 | 17.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.1423 | 18.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.1423 | 18.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.1425 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.1427 | 19.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.1430 | 17.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.2468 | 18.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.2865 | 11.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.2886 | 22.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 301.3490 | 18.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.1959 | 6.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.1962 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.1968 | 5.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.1971 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3035 | 29.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3041 | 27.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3043 | 29.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3047 | 28.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3047 | 28.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3048 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3051 | 13.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3052 | 27.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3052 | 28.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3053 | 14.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3054 | 14.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3056 | 23.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.3059 | 30.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.8877 | 0.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 302.8880 | 36.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 303.3045 | 22.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 303.6473 | 16.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 303.6474 | 16.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 303.6475 | 16.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 303.6483 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2844 | 13.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2845 | 12.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2847 | 13.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2848 | 12.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2849 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2852 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2975 | 0.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2976 | 3.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2987 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2991 | 14.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2994 | 1.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2995 | 15.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2996 | 0.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2996 | 1.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2996 | 1.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2998 | 1.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.2999 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.3000 | 1.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.3001 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.6550 | 15.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.6552 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.6557 | 16.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.6558 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.8987 | 3.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 304.8990 | 3.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1246 | 8.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1390 | 7.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1391 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1395 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1398 | 7.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1401 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1405 | 7.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1562 | 0.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1565 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1568 | 2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1571 | 1.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1572 | 1.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1573 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1573 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1574 | 0.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1574 | 5.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1574 | 6.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1575 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1575 | 5.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1575 | 38.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1576 | 0.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1576 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1576 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1576 | 2.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1582 | 5.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1582 | 6.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.1586 | 5.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.2447 | 3.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 305.2453 | 21.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 306.1309 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 306.1606 | 39.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 306.1608 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 306.3039 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 306.8518 | 8.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 306.8524 | 8.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 306.8525 | 7.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.1156 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.1157 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.1158 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.1160 | 7.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.1161 | 8.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.1164 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.1164 | 7.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.1166 | 7.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 307.3109 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 308.0914 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 308.2945 | 17.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 308.2947 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 308.2954 | 16.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 308.2955 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 308.2958 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.1269 | 8.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.1270 | 8.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.1273 | 8.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.1316 | 12.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.2037 | 19.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.2037 | 20.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.2425 | 13.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.2425 | 14.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 309.2433 | 14.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.2156 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.3098 | 22.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.3101 | 22.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.3101 | 22.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.3103 | 21.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.3106 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.3106 | 21.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.3108 | 22.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 310.8507 | 6.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.1236 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.1250 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.1270 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.1270 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.1274 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.1476 | 14.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.1637 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.1883 | 10.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2540 | 19.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2541 | 20.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2544 | 19.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2546 | 20.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2551 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2551 | 20.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2553 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2557 | 21.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2583 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2584 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2584 | 14.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2585 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2586 | 15.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2586 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2590 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2591 | 14.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2592 | 14.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2592 | 14.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.2936 | 10.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.3651 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.3654 | 14.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.3659 | 15.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.4693 | 14.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.4695 | 15.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 311.9987 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 312.0408 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 312.0408 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 312.0415 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 312.3255 | 24.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 312.3259 | 23.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 312.3622 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.0115 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.0126 | 2.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.0516 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.1617 | 9.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.1756 | 10.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2344 | 17.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2345 | 17.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2347 | 16.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2349 | 16.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2349 | 18.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2350 | 16.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2733 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2734 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2735 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2735 | 16.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2736 | 16.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2737 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2738 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2738 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2739 | 16.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2739 | 17.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2740 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2740 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2740 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2741 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2745 | 15.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2745 | 16.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2746 | 15.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 313.2750 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 314.1208 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.0187 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.0598 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.0895 | 30.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.1261 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.1262 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.1265 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.2139 | 12.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.2165 | 11.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 315.2169 | 11.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 316.1370 | 19.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 316.2116 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 316.3207 | 1.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 316.3209 | 1.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 316.3212 | 13.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 316.9838 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.0163 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.0165 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.0167 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.0168 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.0169 | 1.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.0169 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.1364 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.1365 | 14.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.1728 | 13.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 317.2060 | 20.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 318.2763 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 318.2775 | 1.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 318.2793 | 2.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 319.2990 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 319.2994 | 22.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 319.3000 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 319.3001 | 21.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 320.1442 | 25.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 320.8676 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.1298 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.1315 | 5.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.1316 | 6.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.1679 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2086 | 17.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2088 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2093 | 16.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2097 | 25.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2097 | 25.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2098 | 24.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2098 | 25.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2103 | 24.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2396 | 19.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2401 | 18.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2401 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2405 | 19.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2406 | 19.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.2407 | 18.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.3147 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.3150 | 22.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.3151 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.3159 | 22.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.3230 | 1.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 321.4234 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 323.1463 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 323.1473 | 13.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 323.1476 | 13.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 323.1477 | 14.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 323.1621 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.0579 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.0587 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.0591 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.0594 | 1.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.0596 | 1.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.0597 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.1416 | 15.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.2516 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.3260 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.3268 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 324.3270 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.0369 | 5.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.0386 | 5.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.1974 | 18.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.1979 | 18.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.2698 | 22.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.2734 | 15.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.2739 | 16.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.2741 | 15.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.2742 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.2743 | 15.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 325.2746 | 15.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 326.2858 | 23.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 326.2884 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 326.3045 | 20.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 326.3784 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 326.3787 | 17.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.0779 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.0782 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.0783 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.0784 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2009 | 3.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2014 | 0.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2014 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2014 | 29.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2014 | 30.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2015 | 34.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2016 | 2.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2017 | 31.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2017 | 34.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2018 | 2.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2019 | 31.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2295 | 19.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2297 | 19.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2343 | 20.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2500 | 17.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2518 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2522 | 23.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2522 | 32.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2523 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2523 | 30.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2524 | 3.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2525 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2526 | 29.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2531 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2531 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2531 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2532 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2534 | 34.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2535 | 27.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.2536 | 27.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.9724 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.9728 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.9731 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 327.9736 | 1.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 328.2635 | 14.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 328.2635 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 328.2636 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 328.3211 | 21.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2136 | 23.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2137 | 1.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2140 | 1.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2146 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2146 | 24.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2147 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2148 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2148 | 21.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2150 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2150 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2296 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.2477 | 20.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 329.3162 | 13.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2171 | 1.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2460 | 2.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2781 | 16.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2783 | 15.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2790 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2791 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2792 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2795 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2797 | 15.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.2800 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9467 | 29.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9470 | 2.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9479 | 30.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9479 | 37.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9479 | 38.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9480 | 32.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9480 | 36.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9481 | 28.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9482 | 26.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9482 | 32.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9482 | 38.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9483 | 27.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9483 | 38.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9484 | 29.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9484 | 29.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9484 | 39.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9485 | 29.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9486 | 28.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9486 | 28.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9487 | 30.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9487 | 39.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9488 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9490 | 29.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9490 | 30.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9490 | 30.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9492 | 2.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9493 | 30.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9493 | 38.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9494 | 28.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 330.9504 | 29.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 331.2049 | 9.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 331.2088 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 331.2095 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 331.2098 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3304 | 17.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3306 | 15.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3309 | 15.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3310 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3312 | 0.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3312 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3313 | 1.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3314 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3316 | 1.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3316 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3317 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.3317 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.4063 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.4069 | 1.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.4070 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.4073 | 1.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.4074 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.4075 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 332.4076 | 1.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 333.0610 | 8.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 333.1480 | 7.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 333.1528 | 13.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 333.1687 | 13.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 333.2397 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 333.9550 | 8.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.1249 | 17.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.1254 | 18.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.1255 | 18.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.1256 | 18.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.1259 | 17.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2181 | 21.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2571 | 15.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2577 | 15.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2578 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2579 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2580 | 15.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2581 | 14.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2583 | 14.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2583 | 14.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2592 | 13.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 335.2694 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 336.0872 | 11.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 336.3250 | 21.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 336.3255 | 22.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 336.3260 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 336.3266 | 23.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 336.8447 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 336.9273 | 24.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 336.9278 | 24.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1044 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1046 | 15.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1047 | 14.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1048 | 14.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1053 | 14.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1054 | 15.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1779 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1850 | 1.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1862 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1864 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1866 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1867 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.1877 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2338 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2338 | 15.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2346 | 14.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2351 | 14.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2352 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2727 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2734 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2737 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2738 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2739 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2740 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2742 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2742 | 15.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2743 | 14.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2744 | 15.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2745 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.2751 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.3848 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.3850 | 15.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.3853 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 337.4936 | 15.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.2783 | 23.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3409 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3410 | 21.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3410 | 35.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3413 | 23.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3415 | 32.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3416 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3416 | 3.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3417 | 31.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3417 | 32.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3417 | 33.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3419 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3420 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3421 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3421 | 23.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3422 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3422 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3422 | 23.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3425 | 22.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3431 | 33.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3693 | 1.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.3840 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4020 | 23.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4024 | 23.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4025 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4027 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4029 | 22.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4184 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4528 | 23.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4529 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4531 | 22.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4531 | 23.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.4532 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.5618 | 22.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.5619 | 23.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.5620 | 23.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.5626 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.5628 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.6648 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8414 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8532 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8689 | 32.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8689 | 37.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8690 | 31.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8691 | 6.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8691 | 35.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8692 | 3.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8692 | 31.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8692 | 34.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8693 | 33.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8693 | 37.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8694 | 39.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8695 | 0.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8695 | 3.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8696 | 0.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8696 | 0.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8696 | 38.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8697 | 31.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8697 | 32.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8697 | 35.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8697 | 37.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8698 | 0.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8698 | 0.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8698 | 34.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8698 | 35.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8698 | 37.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8698 | 38.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8699 | 33.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8699 | 34.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8700 | 31.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8700 | 32.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8700 | 36.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8700 | 38.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8700 | 39.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8701 | 31.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8701 | 36.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8701 | 37.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8702 | 0.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8702 | 5.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8702 | 33.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8703 | 34.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8703 | 36.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8704 | 31.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8704 | 39.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8705 | 3.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8705 | 38.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 338.8707 | 3.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.0769 | 9.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.1776 | 12.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2869 | 16.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2874 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2878 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2889 | 5.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2889 | 24.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2890 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2893 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2894 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2895 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2895 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2896 | 2.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2896 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2896 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2897 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2897 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2898 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2898 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2898 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2898 | 16.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2899 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2900 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2903 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2906 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2907 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.2910 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.3503 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.3503 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.3504 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.3507 | 17.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.4005 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.4007 | 16.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.4008 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.4010 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.4012 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.5100 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.5101 | 16.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.5105 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.5109 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.5110 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.7993 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.8002 | 17.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 339.8012 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0263 | 18.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0276 | 17.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0278 | 17.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0278 | 20.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0279 | 20.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0279 | 20.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0280 | 17.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0281 | 20.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0284 | 17.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0284 | 18.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0286 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0286 | 17.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0286 | 18.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0286 | 19.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0286 | 20.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.0288 | 18.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.2268 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.2921 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.3508 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.3567 | 21.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.3572 | 22.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.3575 | 24.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.3935 | 19.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 340.8703 | 31.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.0181 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.0181 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.0184 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.1202 | 12.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.1207 | 12.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.1207 | 13.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.1208 | 14.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.1209 | 13.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.1218 | 12.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.1784 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.2652 | 19.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.2658 | 20.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.2661 | 19.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.2663 | 20.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.2669 | 18.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3030 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3033 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3037 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3040 | 17.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3041 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3041 | 18.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3043 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3044 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3045 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3045 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3045 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3045 | 24.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3046 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3046 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3046 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3047 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3048 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3048 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3048 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3048 | 18.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3048 | 18.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3049 | 19.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3050 | 18.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3051 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3053 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3053 | 18.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 341.3053 | 19.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 342.2463 | 21.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 343.1938 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 343.1940 | 15.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 343.1949 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 343.2853 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 343.2857 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 343.2963 | 11.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.0651 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.0656 | 12.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.0665 | 1.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.0665 | 12.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2275 | 38.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2276 | 31.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2278 | 38.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2279 | 31.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2280 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2280 | 34.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2280 | 34.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2283 | 0.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2283 | 30.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2613 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2614 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2616 | 21.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2617 | 19.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2621 | 2.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2621 | 21.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2622 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2623 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.2627 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.3392 | 2.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.3736 | 20.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.4839 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.8766 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 344.9885 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.0286 | 10.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.0296 | 10.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.1252 | 12.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.1252 | 13.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.1255 | 13.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.1259 | 13.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.1262 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.3072 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.3097 | 1.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.3100 | 1.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.3104 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.3105 | 2.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.3106 | 1.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 346.3110 | 2.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.0244 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.0246 | 1.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.0246 | 9.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.1946 | 20.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.2261 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.2290 | 10.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.2294 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.2298 | 10.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.3291 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 347.3306 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0692 | 17.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0694 | 13.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0702 | 18.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0703 | 6.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0703 | 17.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0705 | 14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0706 | 9.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0707 | 9.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0707 | 17.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0709 | 9.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0709 | 18.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0710 | 9.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0711 | 9.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0714 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.0718 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1315 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1320 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1328 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1838 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1838 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1838 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1839 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1840 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1841 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.1843 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.2940 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.2941 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.2942 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.2943 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.2946 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.2950 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.3268 | 2.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.3272 | 2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.8040 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.8067 | 5.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.8068 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.8070 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 348.8694 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.0581 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.0610 | 9.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.0612 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1655 | 8.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1826 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1827 | 30.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1828 | 6.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1830 | 6.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1831 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1831 | 35.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1833 | 36.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1834 | 0.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1834 | 2.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1834 | 32.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1836 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1836 | 3.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1836 | 5.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1836 | 10.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1836 | 39.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1837 | 0.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1837 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1837 | 3.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1837 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1837 | 9.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1837 | 34.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1837 | 39.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1838 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1838 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1839 | 35.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1840 | 6.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1841 | 34.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.1842 | 6.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.2118 | 20.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.2124 | 21.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.2702 | 23.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.2733 | 16.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.2737 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.2738 | 15.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.2746 | 15.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 349.3456 | 22.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 350.3434 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 350.8629 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 350.8629 | 20.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 352.3199 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 352.3574 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 352.3575 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 352.3576 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 352.9092 | 20.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 353.2293 | 18.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 353.2300 | 18.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 353.2302 | 17.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 353.2656 | 20.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 353.3047 | 18.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 353.9087 | 20.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 353.9091 | 16.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 353.9092 | 20.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 354.1441 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 354.1443 | 6.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 354.1691 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 354.1698 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 354.2782 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 354.2791 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 354.2794 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0429 | 9.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0469 | 10.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0637 | 8.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0637 | 8.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0637 | 8.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0638 | 7.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0640 | 8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0642 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0669 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0683 | 1.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0684 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0689 | 1.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0692 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0694 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0695 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0695 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0697 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0697 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.0749 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.1498 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2076 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2449 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2816 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2818 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2829 | 2.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2830 | 26.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2834 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2834 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2837 | 2.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2839 | 29.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2840 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2842 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2845 | 37.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2846 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2846 | 23.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2846 | 24.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2846 | 28.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2848 | 27.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2849 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2849 | 25.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 355.2853 | 32.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 356.1920 | 6.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 356.1927 | 6.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 356.2943 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 356.2947 | 15.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 356.2953 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1457 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1460 | 17.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1463 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1464 | 18.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1466 | 17.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1468 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1469 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1471 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.1474 | 31.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.2600 | 16.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.2604 | 17.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.2605 | 17.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.2610 | 18.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.2614 | 16.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 357.2783 | 15.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 358.2363 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 358.2766 | 21.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 358.2767 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 358.2770 | 1.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 358.2774 | 2.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 358.2777 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 358.9794 | 20.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.0285 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2410 | 15.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2573 | 24.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2581 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2583 | 14.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2584 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2584 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2585 | 14.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2586 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2587 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2588 | 14.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2589 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.2597 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.3205 | 14.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.3207 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.3212 | 14.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.3723 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.3724 | 14.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.3727 | 14.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.3727 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.3729 | 14.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.4855 | 14.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.4858 | 14.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.4860 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.4864 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 359.7832 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.2006 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.2015 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.2017 | 3.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.2017 | 5.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.2023 | 5.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.2025 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.2562 | 20.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3238 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3618 | 18.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3619 | 2.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3621 | 17.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3622 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3623 | 0.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3623 | 1.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3624 | 17.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3626 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3626 | 1.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3626 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3627 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.3628 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8506 | 36.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8506 | 39.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8508 | 35.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8510 | 3.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8510 | 32.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8511 | 33.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8511 | 37.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8512 | 39.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8514 | 38.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8515 | 32.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8516 | 0.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8516 | 36.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8517 | 0.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8517 | 2.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8517 | 5.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8517 | 33.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8517 | 39.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8519 | 35.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8520 | 38.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8520 | 39.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8521 | 0.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8521 | 38.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8521 | 39.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 360.8522 | 0.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.1828 | 9.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.1831 | 9.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.1832 | 9.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2534 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2728 | 24.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2731 | 24.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2733 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2734 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2734 | 24.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2738 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2741 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2742 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2742 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2743 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2743 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2744 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2745 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2746 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2747 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2752 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.2761 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3362 | 15.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3367 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3370 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3370 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3527 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3529 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3530 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3878 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3881 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3884 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3884 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3888 | 16.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.3890 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.4470 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.5020 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.5023 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.5027 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.5027 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.5027 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.8008 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.8017 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 361.8043 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.0097 | 17.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.0097 | 17.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.0101 | 17.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.2764 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.2768 | 15.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8536 | 32.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8538 | 34.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8539 | 35.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8539 | 38.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8540 | 32.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8540 | 33.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8542 | 34.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8545 | 35.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8547 | 35.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8548 | 31.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8548 | 34.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8549 | 30.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8549 | 34.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8551 | 35.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.8553 | 30.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9259 | 5.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9261 | 5.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9263 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9264 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9266 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9268 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9269 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9270 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9272 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9273 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 362.9276 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2501 | 21.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2502 | 22.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2503 | 22.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2883 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2886 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2886 | 18.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2890 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2890 | 17.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2894 | 16.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2895 | 15.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2896 | 16.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2896 | 16.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2898 | 17.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2900 | 17.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2901 | 15.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2901 | 16.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2901 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.2901 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.3092 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.3523 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.4040 | 15.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.4042 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.4043 | 16.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.4043 | 17.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.4045 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.4047 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.5167 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.5176 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.5180 | 16.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 363.5182 | 15.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.0630 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.0649 | 2.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.0652 | 2.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.0654 | 2.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.0655 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.2608 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.2612 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.3561 | 23.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.3564 | 22.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.3564 | 23.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.3574 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.3578 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 364.3582 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1051 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1054 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1059 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1347 | 17.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1348 | 18.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1351 | 17.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1370 | 16.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1574 | 5.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1575 | 5.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1924 | 18.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1931 | 18.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1932 | 18.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.1936 | 17.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.2779 | 11.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.3013 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.3045 | 18.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.3047 | 17.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.3049 | 18.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 365.3050 | 16.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 366.3710 | 20.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 366.3717 | 21.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 366.3723 | 22.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 366.3723 | 24.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 366.3731 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 366.3733 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 366.3734 | 21.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 366.3736 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.1384 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.1392 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.1397 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.1398 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.1398 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.1400 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.2443 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.2448 | 20.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.2830 | 18.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.2842 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.2845 | 17.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.3199 | 19.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.3200 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.3200 | 18.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.3211 | 18.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.3249 | 19.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 367.3344 | 23.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.3522 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.4242 | 20.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.4243 | 20.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.4245 | 1.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.4249 | 20.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.4252 | 2.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.4255 | 2.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.4257 | 2.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 368.4263 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.0063 | 9.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.0071 | 9.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.0074 | 9.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.1517 | 12.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.1683 | 19.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.1695 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.1698 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.2066 | 20.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.2068 | 19.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.2069 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.2956 | 21.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.2959 | 21.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.2965 | 21.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.2979 | 21.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3502 | 2.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3504 | 22.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3506 | 20.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3508 | 19.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3508 | 23.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3510 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3511 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3512 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3512 | 18.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3516 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3517 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3518 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3518 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.3518 | 23.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.4278 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.4667 | 23.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 369.5806 | 23.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0516 | 9.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0516 | 13.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0528 | 9.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0528 | 9.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0529 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0533 | 13.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0732 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0734 | 1.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.0741 | 1.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.1721 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.1729 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.1750 | 7.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.1753 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.1755 | 7.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.1756 | 7.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.1765 | 7.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.2366 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.2764 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.2765 | 23.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.2771 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.2775 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.2775 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.2775 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.2777 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 370.3544 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.0357 | 7.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.0367 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.0368 | 9.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.0369 | 10.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.0374 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.0380 | 10.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.0386 | 10.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.0395 | 10.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1007 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1007 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1013 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1013 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1014 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1016 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1016 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1614 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1622 | 20.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1622 | 20.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1630 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1630 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1631 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1636 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.1638 | 32.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2268 | 36.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2274 | 39.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2290 | 34.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2391 | 24.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2403 | 28.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2412 | 25.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2636 | 25.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2641 | 25.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2643 | 24.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.2648 | 25.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 371.3269 | 13.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.2740 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.2744 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.2910 | 21.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.2920 | 22.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.2926 | 23.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.2932 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.2935 | 2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.2935 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.3733 | 2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.8709 | 1.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 372.9601 | 5.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 373.2108 | 20.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 373.2114 | 20.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 373.2116 | 20.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 373.2117 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 373.2950 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 373.8840 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 373.8848 | 5.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 373.9021 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 374.3025 | 20.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 374.3259 | 14.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 375.2488 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 376.3170 | 21.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 376.3180 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 376.3180 | 21.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 376.3183 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 376.3194 | 20.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 377.1781 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 377.1782 | 13.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 377.3047 | 16.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 377.3053 | 17.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 379.1509 | 15.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 379.1511 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 379.1512 | 14.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 379.1512 | 15.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 379.2811 | 20.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 379.2815 | 21.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 380.3360 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 380.3512 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 380.3520 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 380.4530 | 6.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 381.1307 | 11.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 381.2236 | 19.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 381.2240 | 19.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 381.2240 | 19.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 381.2251 | 18.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 381.3082 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 382.8405 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.0395 | 8.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.0410 | 8.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.0413 | 8.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.1408 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.1419 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.1419 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.2031 | 18.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.3124 | 22.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.3154 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.3158 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.3161 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 383.3182 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.2549 | 21.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7713 | 27.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7716 | 29.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7718 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7721 | 0.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7721 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7722 | 29.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7723 | 30.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7724 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7725 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7729 | 29.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 384.7735 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1285 | 8.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1294 | 8.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1754 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1762 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1773 | 22.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1773 | 22.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1773 | 36.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1774 | 2.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1774 | 31.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1775 | 22.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1775 | 24.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1777 | 28.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1778 | 39.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1779 | 25.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1780 | 23.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1780 | 33.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1781 | 28.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1781 | 29.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1783 | 30.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1784 | 39.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1786 | 22.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.1790 | 37.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2709 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2728 | 15.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2729 | 24.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2732 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2733 | 17.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2734 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2737 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2737 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2740 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2740 | 15.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2743 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2743 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2743 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2743 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2746 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2750 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2752 | 15.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2915 | 19.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2916 | 20.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2917 | 20.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2920 | 19.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2923 | 19.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.2926 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3383 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3389 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3391 | 15.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3391 | 15.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3436 | 21.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3453 | 19.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3454 | 22.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3556 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3911 | 15.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3917 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3919 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3920 | 15.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.3922 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.5087 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.5088 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.5092 | 15.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.5095 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.5095 | 15.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.7536 | 25.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.7540 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.7548 | 25.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 385.8166 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1566 | 5.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1572 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1572 | 9.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1573 | 11.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1574 | 12.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1575 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1575 | 12.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1576 | 12.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1577 | 12.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1578 | 8.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1578 | 12.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1591 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1591 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 386.1595 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.0055 | 9.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.1794 | 2.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.1802 | 13.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.1805 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.1807 | 3.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.1810 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.1811 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.1815 | 27.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2115 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2120 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2125 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2303 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2626 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2629 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2660 | 20.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2881 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2882 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2883 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2887 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2888 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2889 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2891 | 16.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2893 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2894 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2896 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2897 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2897 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2899 | 15.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2900 | 15.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.2905 | 16.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.3483 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.3544 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.3545 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.3549 | 15.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.4074 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.4078 | 16.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.4081 | 15.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.4083 | 15.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.5255 | 15.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.5257 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.5260 | 15.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.5260 | 16.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 387.8336 | 16.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.1831 | 3.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2169 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2256 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2258 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2482 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2535 | 36.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2539 | 35.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2542 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2545 | 7.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2700 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2796 | 23.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2862 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2864 | 23.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2883 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.2920 | 17.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.3924 | 19.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.3936 | 18.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 388.3936 | 19.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.1219 | 17.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.1866 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.2676 | 3.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.2684 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.2686 | 17.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.2689 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.2690 | 16.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3033 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3034 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3034 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3043 | 17.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3044 | 17.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3044 | 18.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3046 | 16.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3046 | 17.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3046 | 18.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3050 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.3051 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 389.5882 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 390.8536 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.1490 | 16.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.1507 | 16.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.1509 | 15.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.2819 | 23.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.2820 | 22.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.3176 | 23.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.3199 | 18.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.3200 | 17.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.3201 | 18.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.3207 | 17.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.3556 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.7103 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 391.7115 | 6.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 392.0325 | 9.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 392.2920 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 392.2923 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.0188 | 9.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.0195 | 9.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2090 | 2.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2094 | 6.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2095 | 0.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2095 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2096 | 1.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2096 | 38.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2097 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2098 | 3.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2098 | 5.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2099 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2099 | 3.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2099 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2233 | 19.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2237 | 19.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2242 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2242 | 19.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2957 | 22.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2961 | 21.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2964 | 24.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2965 | 23.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2966 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2968 | 21.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2969 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2970 | 23.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2970 | 31.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2972 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2972 | 23.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2973 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2973 | 23.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2974 | 21.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2974 | 21.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2974 | 22.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2975 | 22.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2976 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2976 | 31.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2977 | 30.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2977 | 31.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2978 | 21.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2978 | 30.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2979 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2979 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2980 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2980 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.2985 | 31.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 393.3092 | 13.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 394.0219 | 9.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 394.0754 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 394.0757 | 2.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 394.2118 | 39.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 395.2762 | 21.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 397.0049 | 7.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 397.1858 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 397.1864 | 8.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 397.1865 | 8.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 397.1869 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 397.1872 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 398.3613 | 19.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 398.8357 | 0.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 398.9791 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.0266 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1429 | 16.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1432 | 18.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1434 | 20.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1435 | 22.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1440 | 20.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1441 | 18.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1442 | 22.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1443 | 17.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1444 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1445 | 19.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1445 | 19.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1445 | 19.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1445 | 20.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1446 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1446 | 22.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1447 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1447 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1447 | 17.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1447 | 20.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1448 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1448 | 20.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1449 | 22.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1450 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1450 | 18.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1451 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1464 | 17.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.1766 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.2063 | 21.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.3073 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.3095 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.3470 | 21.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.7693 | 25.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.7694 | 25.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.7695 | 25.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 399.7696 | 24.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 400.2486 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 400.3238 | 1.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 400.3408 | 16.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 400.3411 | 16.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 400.3415 | 15.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.1490 | 6.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.1492 | 5.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2827 | 21.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2832 | 20.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2837 | 21.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2838 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2838 | 2.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2851 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2855 | 17.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2857 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.2865 | 18.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.3406 | 23.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.3409 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.3411 | 23.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.3415 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.3495 | 21.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.4036 | 21.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 401.5238 | 21.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.0680 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.2119 | 9.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.2121 | 8.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.2125 | 5.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.2125 | 6.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.2127 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.3564 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.3569 | 16.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.3571 | 16.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.3577 | 2.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.3579 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.3582 | 2.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 402.3590 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 403.3921 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 403.3931 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 404.2056 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 404.2058 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 404.2063 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 404.2067 | 13.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 404.2072 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 404.2073 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 404.2075 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 404.2082 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.0089 | 6.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.0093 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.0093 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.0093 | 7.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.0098 | 8.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.0099 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.0099 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.0214 | 8.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.1896 | 21.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.1902 | 21.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.1922 | 21.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.2094 | 8.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.2378 | 3.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.2420 | 21.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.2435 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.2443 | 21.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.2447 | 22.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.2452 | 22.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 405.2953 | 22.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.1541 | 13.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.1542 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.1542 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.1543 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.1549 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.1802 | 22.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2521 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2525 | 21.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2528 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2528 | 21.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2528 | 22.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2529 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2529 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2530 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2532 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2532 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2536 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.2536 | 22.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.3205 | 21.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.3207 | 22.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.3230 | 22.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.3736 | 22.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.3738 | 22.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.3742 | 21.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.4946 | 22.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.4954 | 21.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 406.4957 | 22.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 407.0058 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 407.3116 | 23.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 407.3347 | 20.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 407.3354 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 408.2920 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 408.3056 | 20.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1608 | 15.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1616 | 13.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1618 | 14.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1618 | 14.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1618 | 14.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1619 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1619 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1619 | 14.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1620 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1620 | 12.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1620 | 15.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1621 | 12.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1621 | 14.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1622 | 15.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1624 | 12.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1626 | 3.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1630 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1630 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1635 | 12.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1641 | 31.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1837 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1955 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1959 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1962 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1968 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.1985 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2010 | 1.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2292 | 13.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2293 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2294 | 12.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2464 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2466 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2468 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2909 | 22.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2930 | 22.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2980 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2990 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.2998 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.3350 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.3353 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 409.4051 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 410.1646 | 14.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 410.1652 | 13.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 410.1653 | 13.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 410.1653 | 13.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 410.1654 | 14.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 410.1964 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 410.1990 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 410.2569 | 17.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 411.1672 | 14.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 411.1685 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 411.1685 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 411.3574 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 412.7773 | 25.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 412.7774 | 25.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 412.7780 | 25.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2627 | 21.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2646 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2649 | 1.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2653 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2655 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2656 | 22.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2659 | 22.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2661 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2661 | 35.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2663 | 22.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2663 | 23.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2664 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2664 | 22.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2664 | 23.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2665 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2665 | 32.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2665 | 35.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2666 | 35.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2667 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2667 | 31.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2668 | 0.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.2684 | 15.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3034 | 16.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3039 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3040 | 17.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3042 | 17.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3221 | 21.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3225 | 21.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3230 | 22.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3231 | 21.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3357 | 23.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3880 | 23.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.3886 | 22.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.5099 | 22.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.5109 | 23.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 413.7846 | 25.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 414.2456 | 23.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 414.2702 | 2.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 414.2858 | 23.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 414.2979 | 13.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 414.2994 | 13.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.0369 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.0403 | 20.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.1754 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.1765 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2104 | 29.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2105 | 27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2105 | 28.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2112 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2112 | 25.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2115 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2116 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2118 | 24.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2119 | 24.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2123 | 26.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2126 | 1.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2535 | 36.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2551 | 33.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2826 | 16.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2964 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2965 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2977 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2984 | 21.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2989 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2991 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2996 | 2.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.2998 | 2.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 415.3191 | 18.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 416.2574 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 416.3006 | 20.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 416.3021 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 417.2774 | 21.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 418.2586 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 418.8423 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.0366 | 26.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.0377 | 25.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2494 | 18.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2508 | 19.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2518 | 19.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2543 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2544 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2744 | 19.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2753 | 18.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2753 | 19.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.2763 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.3107 | 23.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.3121 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.3122 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.3122 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.3125 | 23.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.3882 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.6896 | 6.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 419.6913 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 420.8167 | 35.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 420.8176 | 38.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 420.8177 | 36.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 420.8184 | 0.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 420.8198 | 0.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2313 | 17.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2314 | 17.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2550 | 20.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2551 | 20.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2553 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2556 | 20.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2560 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2561 | 19.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2701 | 18.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 421.2701 | 19.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 422.1722 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 422.1722 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 422.1726 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 422.1728 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 422.1728 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 422.1729 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1347 | 12.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1349 | 6.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1353 | 12.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1355 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1361 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1816 | 8.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1817 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1818 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1821 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.1823 | 8.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2137 | 19.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2139 | 19.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2139 | 20.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2141 | 18.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2142 | 2.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2146 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2148 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2148 | 19.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2149 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2150 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2150 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2661 | 20.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2841 | 21.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2851 | 20.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2862 | 21.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.2868 | 21.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 425.3234 | 19.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.0480 | 9.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.2605 | 14.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.3564 | 17.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.3569 | 16.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9898 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9906 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9910 | 7.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9913 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9915 | 7.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9917 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9917 | 6.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9917 | 7.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9918 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9918 | 7.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 426.9918 | 7.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 427.0954 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 427.0954 | 1.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 427.2990 | 21.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 427.2992 | 2.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 427.3359 | 22.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.0063 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.0363 | 2.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.0363 | 2.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.0370 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.0372 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3716 | 18.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3719 | 2.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3719 | 17.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3722 | 17.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3726 | 17.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3728 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3732 | 18.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3735 | 2.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3739 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 428.3740 | 2.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.0884 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.0887 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.0890 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.0890 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.0890 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.0891 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.1900 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.1904 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.2010 | 10.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3143 | 22.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3147 | 2.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3149 | 22.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3151 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3176 | 19.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3176 | 20.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3178 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3178 | 19.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3180 | 20.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3188 | 18.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.3739 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 429.4015 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.3874 | 18.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.3883 | 18.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.3888 | 2.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.3889 | 17.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.3892 | 2.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.3894 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.3896 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.8859 | 11.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.8861 | 11.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.8864 | 13.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.8866 | 12.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.8868 | 19.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.8877 | 8.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9131 | 6.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9137 | 5.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9141 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9141 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9142 | 5.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9142 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9143 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9144 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9144 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9145 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9146 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9149 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9150 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 430.9150 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.0948 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.0948 | 13.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.2055 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.2176 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.2179 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.2414 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.4233 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.4244 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.8861 | 17.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 431.8861 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2338 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2357 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2371 | 1.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2372 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2384 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2385 | 1.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2387 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2388 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2389 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2800 | 0.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2800 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2801 | 36.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2803 | 0.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2803 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2804 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2805 | 3.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2805 | 34.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2805 | 39.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2807 | 35.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2810 | 38.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.2821 | 30.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.3251 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.8841 | 21.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.8850 | 14.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.8850 | 18.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 432.8851 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 434.3372 | 17.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 434.7786 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 434.7793 | 4.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 434.7801 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 434.7802 | 3.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 434.7804 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 436.3537 | 18.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 436.3537 | 19.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.1551 | 14.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.1564 | 14.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.1566 | 14.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.1568 | 15.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.1573 | 15.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.1922 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.1934 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.1937 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2352 | 38.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2356 | 5.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2359 | 3.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2359 | 7.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2361 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2362 | 0.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2362 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2363 | 3.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2363 | 3.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2364 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2369 | 37.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.2372 | 0.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.3196 | 13.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.3728 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 437.4434 | 13.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 438.2883 | 21.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 438.2964 | 17.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 438.2968 | 17.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 438.2970 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 439.2029 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 439.2031 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 439.2034 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 439.3403 | 20.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 440.2759 | 12.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 440.2763 | 12.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 440.3121 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 441.1502 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 441.2403 | 16.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 441.2621 | 18.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 441.2625 | 19.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 441.2631 | 19.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 441.2974 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 441.7875 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 443.3320 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 443.3331 | 21.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 443.3338 | 21.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.1523 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.1532 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.1532 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.1541 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.1544 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.2624 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.2631 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.2631 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.2632 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.2633 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.2634 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 444.2636 | 2.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.1202 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.1205 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.1205 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.1206 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.1210 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.2080 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.2329 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.3125 | 18.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.3136 | 17.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.3140 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 445.6355 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 447.1176 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 447.1177 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 447.3436 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 447.3436 | 23.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 447.3446 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 447.4184 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 447.9034 | 24.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2181 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2184 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2187 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2857 | 21.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2866 | 22.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2867 | 21.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2867 | 21.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2871 | 21.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2875 | 21.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 449.2875 | 22.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 450.9929 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 450.9932 | 1.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 451.2960 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 451.2969 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 451.3619 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2739 | 14.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2753 | 15.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2767 | 15.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2768 | 14.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2769 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2773 | 14.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2774 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2776 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 452.2779 | 14.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 453.1807 | 2.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 453.1820 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 453.2106 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 453.3175 | 22.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 453.3193 | 21.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 453.7866 | 25.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 454.2923 | 16.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 454.2924 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 454.2925 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 454.2929 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 454.2935 | 16.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 454.2941 | 15.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 454.3076 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 454.3287 | 15.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 455.2093 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 455.2247 | 11.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 455.2252 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 455.2772 | 18.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 455.3335 | 21.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 455.3338 | 21.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 455.4190 | 11.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 455.5475 | 11.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 456.2346 | 12.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 456.2358 | 11.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 456.2363 | 11.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 457.1996 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 457.2005 | 17.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 457.2008 | 16.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 457.3468 | 22.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 457.3483 | 21.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 457.3492 | 21.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 457.3523 | 21.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 458.8404 | 5.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 458.8424 | 5.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 459.2483 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 459.2492 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 459.2493 | 15.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 459.2514 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 459.4553 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 460.1224 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 460.1270 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 460.2678 | 2.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 460.2695 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 460.2695 | 1.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 460.2696 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 462.1474 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.2753 | 18.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.2771 | 18.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.2771 | 19.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.3009 | 19.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.3024 | 18.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.3024 | 19.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.3027 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.7831 | 3.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.7842 | 3.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 463.9796 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 464.3135 | 18.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 464.8053 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.1352 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.1352 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.1358 | 1.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.1361 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2913 | 13.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2917 | 15.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2919 | 16.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2923 | 12.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2924 | 16.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2925 | 6.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2925 | 15.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2927 | 13.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2927 | 13.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2931 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2932 | 13.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.2949 | 6.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.3276 | 20.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.3279 | 18.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.3283 | 19.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.3293 | 18.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.3294 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.8024 | 1.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.9671 | 1.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 466.9683 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3069 | 18.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3079 | 14.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3080 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3080 | 14.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3083 | 18.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3091 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3091 | 6.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3091 | 6.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3438 | 19.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3440 | 19.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3881 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3899 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.3988 | 6.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.4383 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.4389 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.4390 | 14.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.4393 | 14.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.4394 | 13.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.5684 | 14.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.5684 | 14.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.5684 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 468.5687 | 13.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 469.1819 | 11.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 469.1824 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 469.1824 | 11.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 469.2916 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 469.2920 | 21.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 471.1308 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 471.1317 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 471.1328 | 12.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 471.1329 | 13.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 471.3068 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 471.3653 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.0286 | 1.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.1071 | 25.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.1085 | 23.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.1092 | 27.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.2941 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.3212 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.4509 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.5825 | 13.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 472.8170 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1015 | 26.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1022 | 25.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1023 | 27.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1025 | 25.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1026 | 24.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1027 | 31.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1029 | 28.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1029 | 32.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1033 | 26.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1035 | 35.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1191 | 12.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1196 | 12.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.1199 | 12.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.2780 | 2.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.3439 | 20.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.3443 | 20.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.3444 | 19.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.3450 | 19.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.3973 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.3986 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.3991 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 473.3994 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 474.2315 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 474.2333 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 474.2345 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 474.2575 | 14.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 474.2587 | 14.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 474.9656 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.0963 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2117 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2119 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2130 | 17.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2136 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2142 | 16.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2353 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2972 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2976 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2978 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.2980 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.3743 | 24.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.3748 | 22.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.3757 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 475.3761 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.2745 | 17.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.2753 | 14.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.2763 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.2766 | 14.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.2771 | 14.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.2773 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.3049 | 39.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.3055 | 3.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.3062 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.3063 | 3.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.3065 | 38.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.3072 | 38.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 476.3122 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.1697 | 14.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.1700 | 14.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.1707 | 15.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.1709 | 14.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.1712 | 14.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.1712 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2054 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2054 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2057 | 1.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2057 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2058 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2058 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2060 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2961 | 7.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.2962 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.3164 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.3179 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.3179 | 22.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.3183 | 22.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.3184 | 21.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.3186 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 477.3190 | 22.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2916 | 15.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2923 | 14.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2923 | 15.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2923 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2926 | 15.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2928 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2929 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2930 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2931 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.2937 | 15.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3216 | 22.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3259 | 17.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3276 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3282 | 25.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3283 | 24.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3283 | 24.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3284 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3284 | 25.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3285 | 25.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.3289 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.4249 | 15.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 478.8271 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 479.1863 | 16.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 479.1865 | 15.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 479.1869 | 15.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 479.1872 | 15.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 479.2007 | 7.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3062 | 14.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3077 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3080 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3081 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3089 | 16.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3090 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3091 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3106 | 16.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3421 | 18.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3434 | 17.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3435 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3440 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3821 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3822 | 17.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3825 | 17.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.3826 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.4397 | 17.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.4400 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.4404 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.4408 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.4408 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.4408 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.4409 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.5712 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.5718 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.5722 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.5724 | 17.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.5725 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.5730 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 480.9132 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 481.1995 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 481.2016 | 15.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 481.2618 | 3.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 481.2622 | 3.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 481.2623 | 6.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 481.3109 | 16.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.2663 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.2667 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3220 | 14.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3228 | 17.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3230 | 18.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3235 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3236 | 14.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3236 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3236 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3237 | 15.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3239 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3239 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3239 | 4.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3239 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3240 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3240 | 6.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3240 | 15.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3241 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3241 | 6.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3241 | 6.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3241 | 14.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3242 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3243 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3597 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3600 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3600 | 16.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3605 | 17.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3606 | 5.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3606 | 17.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3610 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3611 | 6.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3612 | 6.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.3978 | 19.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.4558 | 19.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.4561 | 19.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.4567 | 18.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.4918 | 16.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.4929 | 17.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.5879 | 19.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.5881 | 19.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 482.5882 | 18.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 483.6470 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 483.6479 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 483.9788 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 483.9818 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 484.1171 | 2.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 484.1172 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 484.2821 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 484.2823 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 484.2823 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 484.2824 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 484.3153 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 485.1123 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 485.1124 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 485.2900 | 19.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 485.2910 | 18.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 485.3574 | 27.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 485.3577 | 30.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 485.3582 | 4.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 485.3587 | 2.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 486.2967 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 486.2967 | 17.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 486.2995 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 487.3593 | 21.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.2738 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.2891 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.2896 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.2898 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.2903 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.2907 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.2988 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.3943 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 488.5193 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1142 | 11.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1143 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1144 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1148 | 11.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1150 | 12.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1151 | 1.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1151 | 1.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1151 | 11.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1155 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1155 | 1.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.1160 | 9.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2258 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2262 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2263 | 13.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2265 | 13.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2266 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2270 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2272 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2272 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2273 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.2903 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.3384 | 18.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 489.3414 | 17.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.2899 | 14.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.2904 | 6.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.2917 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.2921 | 16.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.2924 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.2927 | 15.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.2939 | 14.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.5353 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 490.7279 | 6.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 491.7927 | 2.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 491.7961 | 1.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 491.7962 | 2.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3064 | 14.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3071 | 14.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3075 | 13.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3079 | 14.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3080 | 6.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3082 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3082 | 6.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3084 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.3090 | 14.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.4759 | 23.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.4766 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.4770 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.4772 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.4774 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.4779 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 492.4780 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 493.2054 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 493.2449 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 493.3467 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 493.3482 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 493.3486 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 493.3505 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3235 | 18.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3237 | 6.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3242 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3244 | 14.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3248 | 6.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3248 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3249 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3252 | 18.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3589 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3596 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3598 | 20.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3623 | 6.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.3987 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.4170 | 6.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.4170 | 6.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.4174 | 6.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.4580 | 14.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.4581 | 14.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.4581 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.5915 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 494.5915 | 15.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 495.1801 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 495.2653 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 495.2654 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 495.2656 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 495.2656 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 495.2659 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 495.2984 | 22.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 495.2995 | 23.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3388 | 7.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3396 | 4.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3399 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3403 | 6.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3736 | 17.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3746 | 18.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3747 | 18.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3764 | 6.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3765 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3886 | 6.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.3952 | 6.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4143 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4147 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4151 | 15.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4154 | 17.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4155 | 16.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4319 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4328 | 6.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4328 | 6.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4331 | 6.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4724 | 15.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4732 | 16.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4734 | 17.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4735 | 15.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.4740 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.6076 | 16.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.6077 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.6078 | 16.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.6082 | 15.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.6082 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.6083 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.6083 | 17.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.9567 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.9570 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 496.9572 | 17.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 497.3386 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.0827 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.0835 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2671 | 6.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2684 | 6.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2812 | 11.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2818 | 11.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2820 | 12.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2822 | 11.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2824 | 12.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2827 | 11.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2828 | 6.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2830 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.2832 | 6.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9012 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9018 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9019 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9020 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9020 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9022 | 5.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9022 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9024 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9025 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9027 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 498.9030 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.1862 | 8.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.1869 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.1870 | 5.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.1877 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.1878 | 8.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.1880 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2241 | 7.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2251 | 7.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2251 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2412 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2417 | 7.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2800 | 7.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2801 | 5.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2801 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2802 | 7.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2802 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2803 | 7.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2803 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2807 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2807 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2819 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2822 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 499.2841 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.1896 | 7.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2723 | 15.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2734 | 16.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2736 | 15.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2741 | 16.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2743 | 14.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2748 | 15.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2759 | 14.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2759 | 24.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2763 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2766 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2774 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2775 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2776 | 14.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2777 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.2786 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.3531 | 14.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.4114 | 14.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.4119 | 15.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.4124 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.4125 | 14.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.4126 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.5456 | 15.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.5463 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.5465 | 14.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.5476 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.9864 | 7.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.9872 | 7.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 500.9889 | 5.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 501.2885 | 11.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 501.2894 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 501.2894 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 501.3749 | 21.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 501.3757 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 501.3757 | 21.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2797 | 3.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2801 | 3.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2899 | 17.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2909 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2917 | 16.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2919 | 24.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2922 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2924 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2932 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2934 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2935 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2936 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.2937 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3683 | 15.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3686 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3689 | 16.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3690 | 16.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3691 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3748 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3754 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3864 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.3866 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.4278 | 16.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.4280 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.4280 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.4280 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.4282 | 15.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.4282 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.4283 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.4285 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.5625 | 15.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.5629 | 16.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.5633 | 15.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.5635 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.5635 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.5638 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.5640 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.5640 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.9132 | 15.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.9133 | 16.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.9149 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 502.9180 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1061 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1065 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1073 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1073 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1082 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1091 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1862 | 15.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1866 | 15.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1869 | 15.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1869 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1869 | 16.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1872 | 15.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.1878 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.2943 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.4070 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 503.8601 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3063 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3065 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3071 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3072 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3073 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3077 | 17.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3078 | 17.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3085 | 17.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3087 | 16.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3089 | 17.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3095 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3424 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3425 | 6.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3430 | 17.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3434 | 25.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3441 | 25.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3442 | 6.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3442 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3443 | 24.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3446 | 24.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.3452 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.4431 | 15.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.4436 | 16.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.4442 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.4443 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 504.5787 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.2011 | 15.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.2022 | 15.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.2025 | 15.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.2032 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.2039 | 16.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.2050 | 16.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.2208 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.2215 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3133 | 16.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3474 | 22.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3488 | 23.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3490 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3495 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3500 | 23.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3501 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3502 | 23.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 505.3507 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.0350 | 1.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.0350 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.2633 | 6.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3118 | 16.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3235 | 17.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3237 | 18.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3240 | 17.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3244 | 18.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3250 | 16.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3585 | 25.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3588 | 24.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.3592 | 25.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.4929 | 21.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.5287 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.5289 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 506.5294 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 507.3273 | 18.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 507.3279 | 19.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 507.3281 | 19.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 507.3284 | 18.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 507.3292 | 19.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 507.3639 | 23.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.2815 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.2821 | 16.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3034 | 18.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3035 | 17.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3386 | 19.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3387 | 15.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3389 | 16.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3390 | 18.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3390 | 19.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3392 | 18.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3394 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3396 | 6.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3397 | 6.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3397 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3397 | 15.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3397 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3399 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3400 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3414 | 15.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3744 | 6.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3747 | 17.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3749 | 19.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3755 | 20.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3756 | 20.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3757 | 18.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3759 | 6.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3764 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3764 | 6.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.3765 | 6.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8629 | 12.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8629 | 15.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8631 | 11.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8633 | 13.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8634 | 14.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8635 | 15.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8635 | 18.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8635 | 19.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8636 | 12.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8637 | 17.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8637 | 20.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8638 | 13.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8640 | 18.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8641 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8641 | 18.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 508.8642 | 22.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 509.2293 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 509.3409 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 509.3626 | 22.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 509.8633 | 17.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 509.8637 | 19.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 509.8638 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 509.8639 | 20.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 509.8640 | 19.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3450 | 23.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3534 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3536 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3538 | 18.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3540 | 17.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3541 | 16.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3541 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3547 | 17.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3548 | 6.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3549 | 17.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3550 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3554 | 6.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3555 | 17.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3558 | 18.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3564 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3889 | 6.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3911 | 19.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3919 | 6.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3921 | 6.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.3921 | 6.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.5281 | 19.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.8598 | 14.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.8614 | 15.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.8618 | 14.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.8621 | 16.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 510.8621 | 20.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 511.2086 | 19.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 511.2092 | 20.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 512.3333 | 12.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 512.4151 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 512.4162 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 512.4164 | 20.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 513.2345 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 513.2953 | 14.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 514.2913 | 14.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.1528 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.1529 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.1539 | 7.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.1567 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.1602 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.1611 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.1614 | 7.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.1623 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.3118 | 16.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.3123 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.3133 | 17.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.3151 | 15.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.3891 | 22.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4116 | 21.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4120 | 20.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4121 | 23.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4123 | 23.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4128 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4132 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4133 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4135 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4135 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4137 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.4138 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.5082 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.5095 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.5102 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 515.5103 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 516.1544 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 516.2759 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 516.3058 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 516.3059 | 14.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 516.3061 | 14.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 516.3064 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 516.3191 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 516.4260 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 517.3203 | 1.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 517.3695 | 20.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 517.3707 | 20.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.2656 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.3224 | 14.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.3229 | 14.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.3237 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.3239 | 15.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.3241 | 17.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.3242 | 15.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.4551 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.4908 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.4917 | 23.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.4921 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.4921 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 518.4931 | 22.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 519.1394 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 519.1396 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 519.1398 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 519.1401 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 519.2510 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 519.2975 | 16.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 519.4956 | 1.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.0650 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3052 | 17.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3057 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3065 | 16.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3328 | 3.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3332 | 0.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3394 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3401 | 6.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3402 | 6.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3404 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.3405 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.4160 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.4768 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.4772 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.4772 | 16.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.4775 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.5075 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.5078 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.5081 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.5082 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.5087 | 22.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.5541 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.6130 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.6132 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.6147 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 520.7984 | 1.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.1672 | 7.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.1684 | 7.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.1686 | 7.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.1689 | 7.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.1690 | 7.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.1691 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.2668 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.2670 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.2671 | 16.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.2672 | 16.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3791 | 26.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3799 | 23.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3799 | 26.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3801 | 26.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3802 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3802 | 25.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3802 | 28.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3802 | 29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3804 | 2.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3805 | 28.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3806 | 27.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3807 | 26.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3808 | 23.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3808 | 26.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3808 | 27.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3812 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3812 | 25.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3813 | 23.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3813 | 24.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3814 | 25.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3814 | 28.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3815 | 28.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3817 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3817 | 25.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3818 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3821 | 26.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3822 | 28.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3825 | 24.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 521.3825 | 27.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3541 | 17.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3551 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3559 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3559 | 7.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3562 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3564 | 6.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3564 | 6.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3565 | 6.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3565 | 6.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3923 | 6.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3924 | 6.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3931 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3932 | 6.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3940 | 6.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3946 | 6.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.3957 | 6.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4110 | 6.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4115 | 6.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4120 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4319 | 17.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4328 | 17.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4330 | 16.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4331 | 17.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4332 | 17.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4333 | 16.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4339 | 16.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4511 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4511 | 6.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4511 | 6.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4511 | 6.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4929 | 17.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4929 | 17.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4930 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4932 | 16.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4932 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4933 | 16.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4933 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4933 | 17.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.4934 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.5962 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.5962 | 1.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.5966 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.5972 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.5972 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6293 | 17.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6304 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6308 | 17.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6309 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6311 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6312 | 16.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6312 | 16.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6313 | 17.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 522.6318 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 523.2125 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 523.3604 | 21.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 523.4999 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 523.5001 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 523.5002 | 17.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 523.5005 | 16.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 523.5006 | 17.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2719 | 17.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2737 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2737 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2739 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2743 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2746 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2747 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2748 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2749 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2749 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2749 | 15.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2750 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2885 | 19.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2936 | 16.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2959 | 17.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2978 | 18.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.2988 | 17.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.3709 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.3710 | 18.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.3711 | 6.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.3711 | 6.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.3722 | 6.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.4125 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.4275 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.4467 | 18.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.4484 | 19.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.4491 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.4664 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.4666 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.5084 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.5087 | 18.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.5088 | 18.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.6466 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.6470 | 19.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 524.6471 | 18.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 525.0050 | 19.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 525.2781 | 15.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 525.3737 | 17.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2067 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2467 | 6.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2872 | 18.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2873 | 19.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2891 | 16.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2893 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2896 | 17.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2897 | 16.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2899 | 19.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2905 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2914 | 15.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2919 | 14.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2920 | 15.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2925 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2934 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2936 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2936 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2936 | 24.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2937 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.2956 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3020 | 5.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3125 | 24.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3279 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3581 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3613 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3699 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3711 | 15.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3714 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3718 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.3745 | 18.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.4301 | 15.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.4309 | 15.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.4310 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.4312 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.4312 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.4314 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.4315 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.4319 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.5688 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.5690 | 15.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.5693 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.5697 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.5698 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.5699 | 15.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.5699 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 526.9302 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 527.1794 | 21.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 527.2028 | 17.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 527.2030 | 18.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 527.2031 | 17.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 527.2039 | 18.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 527.4379 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 527.4392 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3045 | 18.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3056 | 17.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3073 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3078 | 16.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3079 | 16.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3079 | 16.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3082 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3083 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3084 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3085 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3085 | 17.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3091 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3871 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.3886 | 16.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.4470 | 15.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.4470 | 16.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.4471 | 15.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.4471 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.4472 | 15.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.4472 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.5851 | 15.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.5855 | 15.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.5856 | 16.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.5857 | 15.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.5860 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.5863 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 528.9458 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 529.2551 | 6.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 529.3018 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 529.3139 | 15.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 529.4543 | 15.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 529.4548 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.2871 | 3.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.2910 | 16.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.2912 | 17.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3181 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3188 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3192 | 15.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3199 | 16.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3205 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3215 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3235 | 18.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3237 | 16.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3237 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3241 | 17.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3245 | 16.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 530.3246 | 17.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.1555 | 10.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.3859 | 20.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4058 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4067 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4068 | 21.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4072 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4077 | 21.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4079 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4080 | 23.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4084 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 531.4087 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.2257 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.2803 | 6.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3356 | 17.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3371 | 17.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3373 | 15.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3373 | 18.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3383 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3388 | 18.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3392 | 19.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3393 | 16.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3394 | 18.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3396 | 17.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.3396 | 18.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.4379 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.4383 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.4384 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.4385 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.4391 | 1.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.4394 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.4688 | 24.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 532.4697 | 23.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.0773 | 12.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.2658 | 15.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.2669 | 15.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.2678 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3663 | 18.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3775 | 24.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3780 | 22.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3795 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3796 | 23.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3797 | 22.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3800 | 23.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3800 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3811 | 24.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3812 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3813 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3816 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.3824 | 23.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.7856 | 6.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 533.7880 | 7.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 534.2845 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 534.2947 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 534.2954 | 6.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 534.3546 | 16.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 534.5622 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 534.7853 | 6.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 534.7886 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.1637 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.1652 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.1656 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.1659 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.1660 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.1662 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.1663 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.1664 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.3688 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.3703 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.3703 | 17.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 536.3710 | 6.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.1349 | 7.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.1427 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.1649 | 1.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.1655 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3921 | 25.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3933 | 3.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3933 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3944 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3945 | 20.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3949 | 23.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3951 | 23.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3952 | 17.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3952 | 21.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3953 | 3.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3955 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3956 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3957 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3958 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3958 | 3.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3959 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3968 | 26.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.3975 | 3.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4308 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4333 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4341 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4345 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4407 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4521 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4522 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4758 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4909 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4915 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4915 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4918 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4920 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.4944 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.5329 | 23.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.5338 | 23.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.5342 | 24.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 537.6749 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 538.0387 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 538.3498 | 18.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 538.3500 | 5.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 538.3506 | 5.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 538.3863 | 20.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 538.3986 | 24.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 538.5193 | 24.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 539.3958 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 539.3979 | 2.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 540.2752 | 15.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 540.3057 | 15.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 540.3983 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 540.4463 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 540.5331 | 22.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 540.8888 | 24.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 540.8888 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 540.8895 | 24.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 541.1207 | 23.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 541.3281 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 541.3296 | 16.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 541.3299 | 17.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 541.3300 | 16.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 541.3301 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.0680 | 9.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.0688 | 9.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.2909 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.2913 | 16.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.3210 | 15.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.3244 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.3249 | 6.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.4042 | 15.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.4635 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.4647 | 15.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.6037 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.6047 | 15.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 542.8204 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 543.1501 | 7.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 543.1505 | 7.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 543.1507 | 7.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 543.1509 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 543.1510 | 7.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 543.1511 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 543.1514 | 7.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 543.1519 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.2407 | 14.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.2415 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.2462 | 16.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3380 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3394 | 4.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3394 | 24.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3402 | 6.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3404 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3410 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3424 | 16.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3772 | 6.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.3817 | 6.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4187 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4188 | 16.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4190 | 16.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4198 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4372 | 6.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4373 | 5.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4375 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4573 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4771 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4773 | 17.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4774 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4774 | 16.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4775 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4798 | 15.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4800 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4801 | 16.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4802 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4803 | 16.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4804 | 15.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.4810 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6169 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6171 | 17.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6204 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6206 | 15.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6207 | 15.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6209 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6210 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6211 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.6218 | 16.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 544.9901 | 16.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 545.3408 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 545.4013 | 21.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 545.4031 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 545.4036 | 21.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 545.4845 | 15.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 545.4852 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.2550 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.2561 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.2568 | 16.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.2575 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.2951 | 6.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.2958 | 6.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3511 | 17.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3518 | 6.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3521 | 19.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3525 | 18.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3541 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3546 | 6.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3546 | 16.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3551 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3997 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.3999 | 19.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.4002 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.4004 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.4006 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.4009 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.4358 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.4961 | 15.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.4965 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.4966 | 16.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5233 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5237 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5241 | 22.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5242 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5245 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5246 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5698 | 1.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5717 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5719 | 1.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.5725 | 1.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.6264 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.6363 | 16.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.6377 | 16.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 546.9580 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.2829 | 15.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.2831 | 16.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.2833 | 16.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.3555 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.3557 | 17.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.3567 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.3568 | 16.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.3581 | 6.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 547.3590 | 16.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.2704 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.2736 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.2749 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.2751 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.2753 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.2754 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.2756 | 15.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.2761 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3625 | 17.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3662 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3671 | 6.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3688 | 6.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3688 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3688 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3693 | 16.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3699 | 18.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3707 | 17.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3708 | 17.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3709 | 18.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3710 | 18.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.3714 | 17.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.5368 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.5378 | 22.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.5387 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.5860 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 548.5872 | 1.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.2772 | 16.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4124 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4137 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4861 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4864 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4871 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4872 | 3.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4873 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4873 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4875 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4877 | 3.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4878 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4879 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4880 | 1.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4884 | 1.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 549.4890 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.2885 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.2886 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.2887 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.2896 | 17.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.2906 | 17.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3505 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3516 | 18.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3848 | 18.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3859 | 18.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3862 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3863 | 5.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3863 | 18.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3863 | 19.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3865 | 6.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3868 | 18.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3869 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.3870 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.6285 | 2.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.6286 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.6287 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.6292 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 550.6318 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3279 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3281 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3281 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3283 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3285 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3538 | 18.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3541 | 18.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3551 | 19.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 551.3552 | 19.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 552.3287 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 552.3974 | 6.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 552.4012 | 20.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 552.4017 | 24.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3873 | 21.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3879 | 20.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3887 | 23.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3889 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3890 | 22.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3891 | 1.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3895 | 20.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3896 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3896 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3897 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3897 | 22.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3898 | 23.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3900 | 21.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3900 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3901 | 21.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3902 | 23.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.3913 | 20.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.5303 | 21.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.5308 | 23.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.6728 | 23.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 553.7839 | 6.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.2853 | 3.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.2861 | 16.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.2870 | 17.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.2886 | 15.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.3231 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.3233 | 17.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.3235 | 16.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.3249 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.3700 | 23.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.3720 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.3918 | 20.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.3922 | 21.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 554.4608 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.1379 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2739 | 14.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2742 | 33.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2765 | 9.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2765 | 33.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2767 | 2.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2769 | 31.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2770 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2770 | 5.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2771 | 17.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2776 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2776 | 8.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2776 | 35.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2776 | 37.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2777 | 4.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2777 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2779 | 37.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2780 | 8.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2781 | 28.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2788 | 33.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2789 | 31.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2791 | 19.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.2793 | 31.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.3027 | 16.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.3393 | 18.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.3395 | 18.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.3404 | 18.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4186 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4187 | 8.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4188 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4189 | 8.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4192 | 8.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4396 | 20.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4404 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4405 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4421 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.4427 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.5595 | 8.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.5603 | 7.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.5605 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.5615 | 8.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 556.5620 | 8.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 558.2958 | 6.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 558.2960 | 6.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 558.4855 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 559.1247 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 559.1318 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.0777 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.0782 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.0784 | 1.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.0787 | 2.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.0796 | 1.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.3121 | 6.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.3121 | 6.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.3123 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.3679 | 18.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.3713 | 17.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.4109 | 6.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.4700 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.4701 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.4705 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.4712 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.5008 | 21.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.5008 | 22.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.5009 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.5016 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 560.5767 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.3961 | 20.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4104 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4112 | 23.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4116 | 22.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4118 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4119 | 24.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4123 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4124 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4124 | 23.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4137 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.4702 | 2.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.5233 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.5247 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 561.7643 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 562.1596 | 1.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 562.1601 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 562.2597 | 6.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 562.3275 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 562.5166 | 23.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 563.3132 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 563.3136 | 16.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.0499 | 9.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3058 | 14.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3287 | 18.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3642 | 18.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3645 | 17.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3650 | 18.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3652 | 18.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3658 | 5.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3660 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 564.3663 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 565.3090 | 15.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.3206 | 6.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.3213 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.3222 | 15.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.3230 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.3441 | 20.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.3450 | 19.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.3803 | 20.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.3807 | 19.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.4638 | 16.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.4639 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8884 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8890 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8890 | 5.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8892 | 4.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8892 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8897 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8901 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8901 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8902 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8903 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 566.8905 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 567.3248 | 16.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3361 | 17.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3364 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3369 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3370 | 16.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3371 | 17.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3382 | 17.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3386 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3401 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3401 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3401 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3406 | 3.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3414 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.3417 | 15.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.4216 | 16.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.4404 | 5.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.4768 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.4826 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.4832 | 16.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.4832 | 16.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.4833 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.6271 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.6272 | 15.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 568.6275 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 569.3041 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 569.3045 | 6.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 569.4860 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.2593 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.2777 | 15.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.2833 | 16.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3088 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3459 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3494 | 18.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3523 | 17.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3534 | 18.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3543 | 4.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3546 | 16.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3551 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3551 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3551 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3551 | 15.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.3558 | 16.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.4366 | 16.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.4572 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.4583 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.4986 | 15.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.4992 | 16.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.4993 | 16.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.6420 | 15.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.6424 | 16.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 570.6433 | 16.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 571.3573 | 17.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 571.3578 | 17.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 571.3581 | 16.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.2716 | 15.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.2721 | 16.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.2812 | 15.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.2966 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3312 | 17.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3333 | 16.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3676 | 18.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3685 | 6.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3687 | 5.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3687 | 18.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3693 | 5.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3701 | 17.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3707 | 17.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.3717 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 572.4366 | 17.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.2905 | 5.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.3843 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.3850 | 19.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.3853 | 19.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.3855 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.3859 | 18.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.3868 | 18.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.5998 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.6014 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 574.6026 | 1.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.4121 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5014 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5025 | 1.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5029 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5029 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5030 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5030 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5032 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5032 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5033 | 1.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5033 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5034 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5034 | 3.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5035 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5036 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5037 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5037 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5038 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5039 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.5045 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 575.7663 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 576.3856 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 576.4011 | 20.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 576.4022 | 19.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 576.4107 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 576.4107 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.3914 | 17.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5164 | 3.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5168 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5172 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5175 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5180 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5183 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5184 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5185 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5186 | 3.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5188 | 24.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5189 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5190 | 3.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5190 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5191 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5191 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5192 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5193 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5194 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5194 | 1.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5194 | 2.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5196 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5197 | 1.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.5198 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 577.9639 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 578.2568 | 8.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 578.3098 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 578.3454 | 18.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 578.5199 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 578.5221 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 580.2790 | 6.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 580.2792 | 6.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 580.2803 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 580.2803 | 6.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 580.3590 | 19.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 580.3600 | 20.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 580.3602 | 18.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 580.3942 | 18.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 581.3079 | 18.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 581.3083 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 581.3086 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 581.4781 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 581.4861 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 582.2962 | 5.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 582.2964 | 6.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.3206 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.3227 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.3233 | 24.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.3243 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.3244 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.3247 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.3764 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.3765 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.5044 | 3.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.5076 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 583.5081 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 584.3075 | 6.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 584.3088 | 5.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 584.4733 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 584.4733 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 584.4880 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 585.3091 | 6.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 585.3741 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 585.3775 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 585.4728 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 585.5202 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 585.5205 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.3053 | 17.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.3087 | 16.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.3087 | 16.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.3099 | 15.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.4783 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.4802 | 22.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.5148 | 23.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.5149 | 22.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.5150 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.5151 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.5171 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8395 | 21.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8402 | 24.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8403 | 14.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8404 | 20.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8405 | 17.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8405 | 18.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8406 | 19.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8406 | 22.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8407 | 15.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8407 | 19.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8408 | 16.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8409 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8409 | 19.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8410 | 16.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8410 | 17.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8410 | 18.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8411 | 21.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8411 | 21.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8411 | 22.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8412 | 15.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8412 | 18.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8412 | 19.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8412 | 19.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8412 | 20.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8412 | 21.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8412 | 21.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8413 | 16.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8413 | 19.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8413 | 21.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8414 | 16.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8414 | 17.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8414 | 19.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8414 | 20.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8415 | 21.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 12.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 14.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 15.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 15.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 17.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 17.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 18.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 20.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8416 | 21.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8417 | 16.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8417 | 17.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8417 | 20.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8417 | 22.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8418 | 15.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8419 | 15.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8419 | 17.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8419 | 23.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8420 | 15.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8420 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8421 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8421 | 18.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8422 | 13.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8427 | 14.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8430 | 12.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 586.8431 | 13.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 587.3133 | 6.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 587.3139 | 5.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 587.3155 | 6.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 587.5150 | 23.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 587.8407 | 19.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 587.8418 | 24.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 588.3392 | 5.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 588.3432 | 5.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 588.3620 | 20.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 588.5308 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.3009 | 6.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4267 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4276 | 21.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4283 | 21.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4379 | 24.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4411 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4429 | 1.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4430 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4431 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4434 | 23.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.4446 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.5194 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.5198 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 589.5526 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.3217 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.3220 | 16.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.3221 | 15.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.3223 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.3228 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.4242 | 18.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.4246 | 19.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.4253 | 19.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.4259 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.4262 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.4268 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.4273 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 590.4274 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.0721 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.0721 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.3843 | 23.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.3854 | 22.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.5333 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.5336 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.5336 | 3.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.5339 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 591.5358 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 592.3347 | 5.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 592.3370 | 17.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 592.3371 | 17.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 592.3384 | 17.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 593.4378 | 23.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 594.3746 | 18.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 595.3808 | 18.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 595.3813 | 19.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 595.3817 | 19.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 595.3818 | 18.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 596.3093 | 6.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 596.3549 | 19.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 596.3692 | 17.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 596.3706 | 17.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 596.3710 | 17.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 597.2764 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 597.2831 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 597.4878 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 598.3848 | 18.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 598.3860 | 18.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 598.4891 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.2411 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.2412 | 13.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.2418 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.2420 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.2423 | 12.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.3903 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.3906 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.5023 | 2.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.5025 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.5028 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.5030 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.5030 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.5033 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 599.5036 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 600.2897 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 600.2930 | 6.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 600.3656 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 600.4668 | 19.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 600.4671 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 600.4685 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 601.5172 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 601.5179 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 601.5181 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 601.5183 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 601.5186 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 601.5187 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 601.5187 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 601.5189 | 1.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 602.3219 | 5.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 602.5217 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 602.5863 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 602.5866 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 602.5867 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 602.5871 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 602.7745 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.4438 | 20.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5309 | 18.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5317 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5327 | 19.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5335 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5336 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5338 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5339 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5339 | 1.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5339 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5339 | 21.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5341 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5341 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5342 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5342 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5343 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5346 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5347 | 2.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5348 | 2.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5348 | 20.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5349 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5349 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5349 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5350 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5351 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5352 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5353 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5354 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.5358 | 19.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 603.6371 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 604.6014 | 23.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 604.8235 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 604.9402 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.2690 | 6.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.3073 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.3081 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.4231 | 19.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5460 | 16.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5467 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5476 | 16.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5482 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5486 | 2.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5487 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5488 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5489 | 18.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5490 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5491 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5491 | 19.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5492 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5492 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5492 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5493 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5493 | 4.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5493 | 4.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5494 | 1.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5494 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5495 | 1.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5495 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5495 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5496 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5496 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5497 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5497 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5498 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5498 | 1.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5498 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5499 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5500 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5500 | 1.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5500 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5500 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5500 | 4.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5501 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5506 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5511 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.5512 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 605.8230 | 6.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 606.2963 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 606.3733 | 20.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 606.3753 | 18.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 606.3800 | 20.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 606.5526 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.2664 | 11.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.3907 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.3908 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.3910 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.3910 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.3910 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.3915 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.3918 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.4139 | 11.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.5074 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.5079 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.5567 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.5580 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 607.5622 | 11.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.0892 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.0892 | 1.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.0894 | 6.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.0915 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.1923 | 5.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.3096 | 5.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.3912 | 20.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.3917 | 20.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.3935 | 20.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.4287 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.7860 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.8760 | 24.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.8763 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 608.8788 | 24.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 609.2816 | 11.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 609.4303 | 11.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 609.5231 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 609.5231 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 609.5798 | 11.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 610.1838 | 1.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 610.1841 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 610.1846 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 610.1853 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 610.9767 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 611.5387 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 611.5388 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 612.3225 | 17.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 612.3251 | 16.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 612.3257 | 17.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 612.5032 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 612.5191 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 613.1591 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 613.1748 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 613.8277 | 6.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 614.3382 | 18.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 614.3400 | 19.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 614.3412 | 19.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 614.4849 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 615.4971 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 615.5351 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 616.4606 | 17.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.4729 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.4732 | 23.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.4743 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.4754 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.4772 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.5086 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.5095 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.5123 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.8259 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 617.9518 | 6.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 618.0768 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 618.2024 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 618.8184 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 618.9445 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 618.9455 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.0692 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.0698 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.1945 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.1953 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.3203 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.3206 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.4382 | 20.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.4535 | 23.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 619.4557 | 23.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 620.4366 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 620.4373 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3001 | 17.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3005 | 17.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3006 | 18.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3006 | 18.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3012 | 18.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3180 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3196 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3209 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.3218 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.4159 | 17.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.4184 | 17.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.4475 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.4681 | 23.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.4681 | 23.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.4687 | 23.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 621.5717 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 622.3722 | 19.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 622.4052 | 19.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 622.4059 | 21.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 622.4081 | 20.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.2573 | 10.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.3150 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.3150 | 25.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.3162 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.3168 | 24.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.5025 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.5028 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.5030 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.5030 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.5031 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 623.5039 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 624.3679 | 17.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 624.8212 | 6.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.1494 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.1505 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.2379 | 10.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.2746 | 10.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.5184 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.5189 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.5190 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.5193 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.5193 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.5194 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 625.5196 | 4.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 626.4034 | 19.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5321 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5324 | 17.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5329 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5329 | 16.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5330 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5331 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5331 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5332 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5334 | 18.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5337 | 18.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5340 | 2.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5343 | 24.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5345 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5347 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5348 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5349 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5350 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5352 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5353 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.5782 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 627.6379 | 2.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.4990 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.5332 | 19.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.5358 | 1.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.5973 | 24.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6009 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6009 | 23.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6011 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6013 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6015 | 22.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6015 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6018 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6019 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 628.6026 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5448 | 3.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5465 | 1.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5481 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5482 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5482 | 18.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5485 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5488 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5491 | 2.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5493 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.5495 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.6026 | 1.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 629.6038 | 1.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.0701 | 1.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.0701 | 7.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.0701 | 7.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.0711 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.0716 | 6.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.3742 | 20.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.5493 | 4.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.6169 | 23.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.6171 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.6179 | 23.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 630.6184 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 631.5597 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 631.5613 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 631.5614 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 631.5615 | 2.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 631.5623 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 631.8267 | 6.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 632.6289 | 21.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 633.3877 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 633.4525 | 21.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 633.4537 | 20.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.3072 | 16.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4047 | 20.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4502 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4502 | 26.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4510 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4515 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4516 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4517 | 19.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4519 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4522 | 29.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4524 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4527 | 28.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4528 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4530 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4535 | 19.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4537 | 18.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.4548 | 25.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8741 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8757 | 5.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8758 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8764 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8768 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8770 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8772 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8773 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8773 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 634.8776 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 635.0991 | 8.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 635.1005 | 7.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 635.1005 | 7.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 635.1010 | 8.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 635.1036 | 7.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 635.5385 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 635.8121 | 6.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 636.0838 | 6.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 636.0841 | 3.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 636.0845 | 4.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 636.0852 | 3.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 636.3878 | 17.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 636.3881 | 19.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 636.4187 | 19.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 639.4069 | 18.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 639.4069 | 19.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 639.4070 | 18.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 639.4075 | 19.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 640.3382 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 640.3415 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 640.5519 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 641.3086 | 23.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 641.3092 | 22.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 641.3092 | 22.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 642.5154 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 642.5790 | 23.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 642.5809 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 643.2836 | 15.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 643.2842 | 16.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 643.2843 | 16.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 643.2854 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 643.2857 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 643.2864 | 4.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 643.5221 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 643.5294 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 644.5941 | 23.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 644.5943 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 644.5952 | 24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 645.2983 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 645.2998 | 18.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 645.3004 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 645.3006 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 645.5035 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 645.5053 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 645.5059 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 645.5410 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 646.4027 | 19.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 646.6088 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.3901 | 23.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.3913 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.4573 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.4574 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.4581 | 23.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.4582 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.4583 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.4584 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.4588 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 647.4595 | 23.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 648.3886 | 20.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 648.4214 | 19.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 648.4230 | 20.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 648.6267 | 22.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 648.6290 | 23.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 648.6295 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 649.0787 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 649.0797 | 2.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 649.3471 | 6.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 649.4486 | 19.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 649.5179 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 649.5183 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 649.5183 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 649.5185 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 650.4023 | 18.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 650.4378 | 20.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 650.4378 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 650.4389 | 20.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 650.4747 | 4.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5340 | 4.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5340 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5342 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5343 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5343 | 4.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5346 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5347 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5347 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 651.5348 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 652.0508 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 652.0517 | 6.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 652.0523 | 7.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 652.0530 | 7.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 652.0533 | 7.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 653.4417 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 653.5482 | 4.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 653.5484 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 653.5488 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 653.5492 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 653.5493 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 653.5497 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.5605 | 3.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.5611 | 2.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.5635 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.5638 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.5639 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.5641 | 2.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.5642 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.7490 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 655.9494 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 656.5291 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 656.5666 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 657.6950 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 657.7792 | 7.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 657.8636 | 7.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 657.9464 | 7.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 658.0280 | 7.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 658.3492 | 6.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 658.3512 | 5.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 658.3620 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 659.6731 | 7.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 659.7494 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 659.8302 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 659.9843 | 7.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 660.2704 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 660.3393 | 6.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 661.1488 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 661.5491 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 661.7494 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 661.9511 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 662.3878 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 662.3997 | 18.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 662.4045 | 20.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 662.4373 | 19.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 662.4437 | 4.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4522 | 2.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4526 | 22.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4529 | 23.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4539 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4543 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4544 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4545 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4547 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4557 | 2.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4653 | 20.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4957 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4962 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4964 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.4975 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.5007 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.5613 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.5613 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.5613 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.5619 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 663.5624 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1159 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1164 | 6.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1164 | 9.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1164 | 9.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1166 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1168 | 2.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1170 | 9.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1171 | 9.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1173 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1176 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1177 | 2.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1178 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.1209 | 9.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.4178 | 19.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.4178 | 20.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.4571 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.4625 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.5256 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.5267 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.5278 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 664.8177 | 19.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 665.4435 | 17.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 665.4956 | 23.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 665.5087 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 665.5127 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 666.4605 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 666.4619 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 666.4623 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 666.6041 | 1.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 667.3395 | 7.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 667.5236 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 667.5259 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 667.5260 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 667.5266 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 667.5271 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 667.5278 | 23.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.0237 | 7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.3176 | 6.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.3252 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.3505 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.4929 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.5901 | 21.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.5919 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.5929 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.5938 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.5941 | 23.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.5957 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 668.5977 | 21.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 669.5386 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 669.5416 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 669.5432 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 669.6005 | 22.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 669.7734 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 670.5233 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 670.6088 | 21.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 670.6096 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 670.6101 | 23.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 670.6144 | 23.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 672.4196 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 672.5255 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 672.6221 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 672.6231 | 22.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 672.6251 | 21.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 673.5367 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 673.5369 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 673.5372 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 674.0338 | 7.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 674.0356 | 7.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 674.5107 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 674.5114 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.4798 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.4805 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5411 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5420 | 20.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5422 | 5.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5427 | 20.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5431 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5432 | 5.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5433 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5435 | 18.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5440 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.5445 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.6729 | 22.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.6751 | 1.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.6765 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.6770 | 23.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.8606 | 7.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 675.8610 | 6.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.3526 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.3566 | 7.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.4183 | 18.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.4530 | 20.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.4897 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.4903 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.4906 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.4977 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.6399 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.8653 | 6.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.8667 | 6.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 676.9296 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 677.4772 | 21.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4332 | 19.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4743 | 24.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4754 | 19.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4755 | 25.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4755 | 28.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4757 | 18.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4758 | 28.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4765 | 25.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4767 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4769 | 2.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4771 | 28.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4779 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4779 | 33.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4781 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4781 | 19.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4787 | 24.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4790 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4792 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4793 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4796 | 26.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4799 | 37.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4805 | 24.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4805 | 26.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4811 | 26.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4813 | 27.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.4996 | 19.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5011 | 19.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5054 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5055 | 20.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5056 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5059 | 20.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5062 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5063 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5064 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5067 | 5.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5069 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5071 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5071 | 21.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5078 | 3.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5436 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 678.5482 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 680.4787 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 680.4790 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 680.4796 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 680.4797 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 680.4801 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 682.2529 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 682.2538 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 682.5611 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 682.5614 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 683.4325 | 18.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 683.4334 | 18.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 683.4336 | 19.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 683.4338 | 19.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.2014 | 1.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.2016 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.2026 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.2031 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.2033 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.2034 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.2035 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.3114 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 684.8677 | 6.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4352 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4352 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4352 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4354 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4355 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4355 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4357 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4357 | 23.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.4378 | 21.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.5914 | 23.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 685.7507 | 23.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 686.0979 | 9.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 686.5387 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 687.4414 | 1.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 688.4901 | 3.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 688.4914 | 3.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 688.4919 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 689.5574 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 689.5583 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 689.5583 | 5.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 689.5586 | 5.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 689.5587 | 5.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 689.5587 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5056 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5060 | 3.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5062 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5064 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5064 | 3.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5418 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5421 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5422 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.5432 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.7890 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 690.9318 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 691.0750 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 691.2181 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 691.3609 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5210 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5211 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5213 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5214 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5217 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5226 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5319 | 20.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5450 | 19.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5455 | 20.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5467 | 20.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5549 | 20.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5554 | 20.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5559 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5566 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5567 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5568 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5572 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5573 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5576 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 692.5577 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 693.4745 | 19.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 693.5427 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 694.6465 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 694.7850 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 694.7868 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 694.7868 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 694.9261 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 694.9298 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 694.9328 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 694.9332 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.0749 | 6.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.0755 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.1303 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.1338 | 2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.2180 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.2200 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.3632 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.5068 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 695.8574 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 696.1191 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 696.1200 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 697.1021 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 697.1022 | 2.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 697.1022 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 697.1025 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 697.1039 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 697.1059 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 697.5230 | 20.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 699.4035 | 2.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 699.4061 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4853 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4870 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4874 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4875 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4879 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4884 | 20.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4892 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4895 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.4895 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.5262 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 700.5262 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5570 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5572 | 21.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5575 | 20.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5583 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5584 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5586 | 5.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5586 | 5.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5587 | 5.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5592 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5594 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5677 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 701.5684 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.2143 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5017 | 20.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5053 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5055 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5060 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5061 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5062 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5399 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5414 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5424 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5424 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.5429 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8642 | 5.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8643 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8646 | 24.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8647 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8649 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8649 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8653 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8653 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 702.8653 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5679 | 14.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5728 | 6.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5734 | 18.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5734 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5737 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5740 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5740 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5742 | 19.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5744 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5750 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5750 | 5.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5751 | 3.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5753 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5755 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.5777 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.6166 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.6175 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.6397 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.6854 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.6855 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.6856 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.6857 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 703.6863 | 5.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.4491 | 20.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5190 | 5.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5207 | 2.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5209 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5212 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5216 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5218 | 20.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5218 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5220 | 19.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5220 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5220 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5221 | 20.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5222 | 20.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5223 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5225 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5225 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5228 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5229 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5229 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5232 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5233 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5568 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5598 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5599 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5603 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.5759 | 18.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 704.6337 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.5843 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.5854 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.5868 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.5868 | 21.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.5889 | 20.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.7992 | 6.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.9403 | 6.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.9428 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.9429 | 6.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 705.9436 | 6.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.0866 | 6.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.0875 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.2309 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.2313 | 6.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.2339 | 6.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.2340 | 6.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.3730 | 6.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.3750 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5181 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5355 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5360 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5363 | 2.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5366 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5372 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5376 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5376 | 5.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5376 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5376 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5376 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5382 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5383 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5384 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5388 | 16.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5761 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5763 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5768 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.5888 | 20.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.6026 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.6476 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.6483 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.6483 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 706.6492 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.2222 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.3642 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.3650 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.4894 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.4895 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.4902 | 1.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.4908 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.4911 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.4921 | 20.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.5079 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.5394 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.5741 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 707.6508 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 708.4796 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 708.4814 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 708.5104 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 708.5104 | 2.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 708.5105 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 708.5109 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 708.5110 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 708.5463 | 21.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.4692 | 17.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.5467 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.6508 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.6517 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.6525 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.6546 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.7906 | 6.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.7951 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.7952 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.7958 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.7967 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.8644 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.9390 | 6.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.9391 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.9393 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.9404 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.9406 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 709.9413 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.0821 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.0826 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.0828 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.0849 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.1199 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.1248 | 1.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.1256 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.2265 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.2265 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.2266 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.2287 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.3701 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.3709 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.3712 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.3721 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.5137 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.5143 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 710.5155 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 711.1267 | 2.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 711.1284 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 711.3779 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 711.3783 | 7.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 711.3800 | 6.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 711.6515 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 711.7922 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 711.8806 | 7.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 712.1147 | 2.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 712.1153 | 2.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 712.2238 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 712.2259 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 712.3722 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 712.4886 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 712.5096 | 5.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 713.4990 | 5.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 713.8546 | 7.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.4793 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5032 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5048 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5051 | 3.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5061 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5061 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5062 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5303 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5366 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.5635 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.6474 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.7305 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.8132 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 714.8971 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.2231 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.3011 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.3024 | 1.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.3028 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.3064 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.3655 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.3692 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.5051 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.6537 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.7920 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.7972 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 715.9419 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5207 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5208 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5219 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5221 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5222 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5224 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5224 | 3.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5224 | 20.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5226 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5226 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5226 | 24.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5228 | 21.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5232 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5238 | 20.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5239 | 20.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5492 | 1.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5504 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5540 | 20.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5546 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5556 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5570 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5571 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5573 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5578 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5586 | 21.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 716.5588 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 717.3965 | 7.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 717.4856 | 7.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 717.5641 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 717.5786 | 7.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 717.6705 | 7.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5362 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5364 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5364 | 21.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5365 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5367 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5367 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5368 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5369 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5372 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5373 | 3.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5377 | 3.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5378 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5379 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5380 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5385 | 20.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5386 | 18.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5390 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5393 | 20.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5396 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5398 | 21.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5404 | 19.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5404 | 19.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5405 | 19.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5410 | 19.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5420 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5430 | 19.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5439 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5459 | 18.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5467 | 18.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5543 | 17.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5598 | 20.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5602 | 21.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5635 | 18.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5640 | 20.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5641 | 20.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5645 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5647 | 18.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5664 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5665 | 18.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5668 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5672 | 20.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5682 | 20.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5686 | 18.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5689 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5705 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5711 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5727 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5730 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5731 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5731 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5734 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5735 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5735 | 19.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5736 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5738 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.5738 | 18.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 718.7750 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 719.5598 | 19.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 719.5700 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 719.5706 | 20.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 719.5721 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 719.5744 | 19.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 720.3850 | 6.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 720.4807 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 720.5519 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 720.5529 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 720.5532 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 720.5533 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 720.5542 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 720.5867 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 721.3883 | 6.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 721.5046 | 1.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 721.5054 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 721.5063 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 721.5066 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 721.5568 | 4.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 721.5819 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.4990 | 26.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5006 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5006 | 18.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5007 | 23.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5007 | 25.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5017 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5020 | 25.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5021 | 2.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5029 | 27.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5032 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5032 | 31.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5033 | 19.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5033 | 28.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5037 | 25.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5037 | 26.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5037 | 28.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5038 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5043 | 26.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5046 | 27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5047 | 26.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5050 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5051 | 37.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5053 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5056 | 27.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5059 | 19.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5064 | 36.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5069 | 31.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5069 | 32.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5073 | 36.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5084 | 2.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5084 | 31.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5106 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5270 | 21.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5518 | 21.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5533 | 23.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5537 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5537 | 21.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 722.5540 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 723.5351 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 723.5360 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 723.5362 | 20.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 723.5377 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 723.5386 | 5.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 723.9464 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.2340 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5240 | 2.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5243 | 20.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5243 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5252 | 4.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5255 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5264 | 21.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5265 | 2.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5266 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5268 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5269 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5272 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.5302 | 20.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 724.9650 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5311 | 21.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5528 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5541 | 20.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5551 | 19.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5552 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5554 | 5.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5563 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5563 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 725.5565 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5027 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5038 | 20.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5038 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5040 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5041 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5043 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5045 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5067 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5095 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5387 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5391 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5398 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5398 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5422 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5504 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.5885 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.6216 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 726.8465 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 727.1247 | 2.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 727.4594 | 19.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 727.4597 | 18.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 727.4600 | 19.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 727.5138 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 727.5684 | 20.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 727.5705 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 728.5187 | 19.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 728.5192 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 728.5193 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 728.5196 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 728.5198 | 21.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 728.5198 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 728.5513 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 728.5581 | 2.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 729.0457 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 729.3890 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 729.5893 | 5.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 729.5895 | 5.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 729.5899 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 729.5904 | 5.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5351 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5365 | 18.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5366 | 20.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5368 | 5.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5368 | 21.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5368 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5370 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5370 | 20.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5370 | 20.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5372 | 3.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5373 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5376 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5379 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5379 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5379 | 19.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5379 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5379 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5381 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5381 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5384 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5704 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5740 | 3.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5742 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 730.5759 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.3759 | 6.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.5755 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.5999 | 20.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.6032 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.6039 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.6044 | 5.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.6044 | 5.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.6046 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.6046 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.6047 | 5.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 731.6059 | 19.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.4717 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.4722 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.4830 | 21.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.4866 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.4944 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5026 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5038 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5078 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5485 | 23.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5520 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5522 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5525 | 3.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5529 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5530 | 8.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5531 | 6.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5532 | 6.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5536 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5537 | 6.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5538 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5538 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5538 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5539 | 20.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5539 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5540 | 2.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5540 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5541 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5543 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5544 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5877 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5945 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5946 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.5949 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6100 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6160 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6175 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6209 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6663 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6664 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6665 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6666 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.6667 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.7135 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.7143 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.7144 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.7147 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.7153 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.7323 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.8784 | 24.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 732.8797 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 733.5121 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 733.5559 | 19.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 733.5950 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 733.6214 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.4955 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.4962 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.4962 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.4976 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5601 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5604 | 5.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5619 | 5.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5645 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5647 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5652 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5657 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5658 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5668 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5671 | 3.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.5677 | 2.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.6730 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.6736 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.7507 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 734.7533 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 735.5677 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 735.5677 | 23.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5082 | 20.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5111 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5113 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5115 | 19.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5120 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5121 | 21.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5132 | 5.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5415 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5416 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5418 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5420 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 736.5424 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2848 | 1.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2852 | 1.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2857 | 1.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2861 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2863 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2865 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2865 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2866 | 5.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.2869 | 1.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.3700 | 22.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.3989 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.3990 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.3995 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.4004 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.4009 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 737.5760 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.2878 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5049 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5051 | 3.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5054 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5056 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5056 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5062 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5076 | 20.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5105 | 20.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5402 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5411 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.5424 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 738.7409 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 739.5138 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 739.5483 | 3.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5213 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5213 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5214 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5219 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5268 | 21.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5326 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5391 | 20.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5428 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5496 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5503 | 20.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5534 | 20.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 740.5542 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 741.5290 | 5.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 741.5298 | 5.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 741.5306 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 741.5309 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5345 | 20.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5348 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5368 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5368 | 20.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5369 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5371 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5372 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5373 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5374 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5661 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5706 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5722 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 742.5732 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 743.4012 | 6.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 743.5407 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.4808 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.4923 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5513 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5521 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5525 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5527 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5527 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5531 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5531 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5535 | 24.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5539 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5539 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5540 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5541 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5543 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5543 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5544 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5545 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5550 | 24.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5567 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5855 | 24.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5869 | 20.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5880 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5883 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5884 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5885 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5888 | 20.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5892 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5960 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5970 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.5991 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.6669 | 3.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.6673 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.6675 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 744.6677 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 745.4916 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 745.5944 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5087 | 2.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5097 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5107 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5441 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5646 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5647 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5668 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5674 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5677 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5678 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5678 | 4.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5679 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5680 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5681 | 5.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5682 | 3.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5686 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5686 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5687 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5687 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5687 | 18.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5689 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5689 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5691 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5691 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5692 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5730 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5742 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5747 | 17.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5747 | 20.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5757 | 21.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5765 | 18.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5809 | 19.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5892 | 22.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5906 | 19.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5921 | 24.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5933 | 23.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5962 | 19.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5979 | 19.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5989 | 20.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5992 | 18.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.5995 | 24.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6010 | 23.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6011 | 21.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6012 | 20.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6016 | 19.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6018 | 5.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6022 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6025 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6027 | 20.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6031 | 21.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6033 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6034 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6036 | 4.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6037 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6037 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6037 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6039 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6041 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6045 | 4.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6138 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6815 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.6824 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 746.8975 | 6.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.3984 | 6.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.4036 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.5791 | 24.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.5835 | 20.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.5877 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.5966 | 20.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.6030 | 21.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.6039 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 747.8981 | 6.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 748.5250 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 748.5256 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 748.5265 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 748.5270 | 2.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 748.5292 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 748.5490 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 749.3762 | 7.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 749.5287 | 3.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 749.5303 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 749.5314 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 749.5744 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 749.5864 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5022 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5382 | 20.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5401 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5415 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5417 | 2.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5417 | 24.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5418 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5425 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5607 | 4.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 750.5616 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 751.5431 | 4.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5199 | 20.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5201 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5205 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5211 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5213 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5220 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5228 | 22.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5258 | 20.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5270 | 20.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5441 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5511 | 20.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5525 | 20.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5533 | 21.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5547 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5549 | 0.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5563 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5567 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5573 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5575 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5576 | 2.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5582 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 752.5583 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 753.0571 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 753.0577 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 753.0583 | 1.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 753.2467 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 753.2529 | 7.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 753.2559 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 753.2560 | 7.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 753.2560 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.2625 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5344 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5351 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5354 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5355 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5356 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5356 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5357 | 21.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5357 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5358 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5360 | 21.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5360 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5363 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5368 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5371 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5372 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5378 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5685 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.5693 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.6978 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.6981 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.6984 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.6985 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.6985 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.8648 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.8655 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.8667 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 754.8680 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 755.5362 | 4.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 755.5401 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 755.9051 | 6.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.4084 | 6.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5508 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5519 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5519 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5522 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5522 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5526 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5526 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5531 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 756.5749 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 757.4109 | 2.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 757.6312 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.2195 | 2.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.2218 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.2219 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.2221 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.2223 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.2223 | 2.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.2750 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.3373 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.4906 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.4915 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.4918 | 19.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.4925 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.4955 | 21.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.4973 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5288 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5665 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5672 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5685 | 20.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5685 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5686 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5687 | 6.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5687 | 6.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5688 | 7.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5688 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5688 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5689 | 20.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5691 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5691 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5693 | 2.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5693 | 20.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5694 | 6.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5695 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5696 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5696 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5699 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5700 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5700 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5701 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5702 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.5702 | 5.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.6029 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.6106 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.6132 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.6839 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.6840 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.6840 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.6841 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 758.6849 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 759.2672 | 7.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 759.2672 | 7.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 759.2680 | 7.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 759.2683 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 759.2685 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 759.2713 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5026 | 21.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5085 | 21.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5113 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5118 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5154 | 20.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5270 | 21.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5280 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5287 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5368 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5824 | 9.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5833 | 8.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5834 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5837 | 8.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5838 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5839 | 5.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5839 | 7.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5841 | 6.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5843 | 5.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5844 | 5.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5844 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5844 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5845 | 21.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5846 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5847 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5848 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5848 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5849 | 3.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5849 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5849 | 20.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5850 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5852 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5854 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5854 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5855 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5855 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5856 | 7.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5857 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.5860 | 9.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6259 | 4.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6270 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6290 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6291 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6294 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6295 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6296 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6317 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6489 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6491 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6498 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6783 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6799 | 21.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6994 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6997 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.6998 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7000 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7001 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7002 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7002 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7004 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7468 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7483 | 21.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7483 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.7486 | 21.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.8199 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.8208 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.9171 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 760.9176 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 761.5868 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 761.5875 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 761.5876 | 5.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 761.5880 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 761.5882 | 5.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 761.5885 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 761.6514 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5027 | 3.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5029 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5033 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5038 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5040 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5053 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5264 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5269 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5271 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5271 | 18.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5272 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5273 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5277 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5277 | 20.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5277 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5280 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5283 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5294 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5296 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5410 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5422 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5899 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5903 | 5.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5926 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 762.5955 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 763.5058 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 763.5944 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 763.5947 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 763.5950 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 763.5951 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 763.5983 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5199 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5215 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5216 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5217 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5220 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5222 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5289 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5413 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5414 | 4.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5420 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5421 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5421 | 5.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5426 | 5.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5430 | 5.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5432 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5449 | 2.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5563 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5565 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5571 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 764.5572 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 765.5459 | 19.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5350 | 27.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5353 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5354 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5371 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5372 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5384 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5387 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5693 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5723 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5730 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5731 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5734 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5738 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5744 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5752 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.5809 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 766.8947 | 6.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 767.5357 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 767.5439 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 767.5466 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 767.5660 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.4608 | 18.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.4783 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.4788 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.4816 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.4912 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.4955 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.4963 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5495 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5509 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5511 | 17.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5523 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5526 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5527 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5538 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5538 | 24.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5542 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5542 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5552 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5554 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5567 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5568 | 24.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5878 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5880 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5883 | 5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5891 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5892 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5893 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5925 | 3.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5963 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5969 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5981 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.5987 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.6006 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.6008 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.6688 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.6690 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.6692 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 768.6696 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 769.5541 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 769.5555 | 2.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 769.5576 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 769.5882 | 22.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 769.5910 | 4.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5078 | 5.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5080 | 6.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5083 | 5.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5104 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5120 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5640 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5662 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5662 | 3.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.5689 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.6002 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.6013 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.6017 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.6019 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.6030 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.6045 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.8520 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.8520 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.8524 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.8526 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.8527 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 770.8528 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.4837 | 18.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.4850 | 19.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.4863 | 19.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5111 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5125 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5127 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5131 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5134 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5135 | 1.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5137 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5138 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5138 | 1.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5145 | 1.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5154 | 1.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5161 | 1.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.5733 | 20.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 771.6069 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.2732 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.2742 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5235 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5243 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5728 | 3.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5783 | 3.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5794 | 3.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5797 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5802 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5810 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5845 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5846 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5848 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5849 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5849 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5849 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5852 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5858 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5877 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.5888 | 19.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6131 | 20.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6150 | 20.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6175 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6177 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6177 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6177 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6178 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6182 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6190 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 772.6201 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 773.5801 | 18.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 773.5875 | 5.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5387 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5409 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5413 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5471 | 20.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5629 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5977 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5987 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5990 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5994 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.5996 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6000 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6002 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6003 | 5.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6010 | 24.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6015 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6027 | 4.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6044 | 2.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6216 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6308 | 20.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6324 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6337 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6339 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6340 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6340 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6342 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6342 | 20.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 774.6357 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 775.5974 | 24.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 775.6082 | 19.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 775.6420 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.2340 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5546 | 3.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5548 | 4.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5564 | 0.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5572 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5572 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5576 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5578 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5581 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5788 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5790 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5795 | 5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5796 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 776.5803 | 20.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 777.2319 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 777.5615 | 3.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5345 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5346 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5351 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5355 | 20.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5360 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5361 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5364 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5367 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5367 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5369 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5372 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5374 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5385 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5391 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5410 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5460 | 20.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5523 | 20.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5681 | 4.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5691 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5693 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5705 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5719 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 778.5742 | 2.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 779.3411 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 779.4329 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 779.5242 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 779.5432 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 779.6149 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 779.7961 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 779.8861 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 779.9734 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5497 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5509 | 20.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5511 | 20.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5511 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5512 | 20.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5512 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5513 | 2.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5514 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5514 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5517 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5521 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5522 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5523 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5525 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5527 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5527 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5532 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5538 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5547 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5883 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5886 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.5898 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.7131 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 780.7157 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 781.5621 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 781.5623 | 24.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 781.5864 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.0616 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.0632 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.4140 | 6.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.4821 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.4872 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5020 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5035 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5628 | 5.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5642 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5644 | 6.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5653 | 6.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5665 | 5.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5666 | 5.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5666 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5669 | 25.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5671 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5672 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5673 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5674 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5677 | 23.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5679 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5679 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5680 | 21.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5682 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5682 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5685 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5690 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5690 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5691 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5692 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5694 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5696 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.5747 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6072 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6076 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6082 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6082 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6474 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6637 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6651 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6661 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.6862 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.7321 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.7322 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.7324 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.7325 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.9035 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.9040 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 782.9067 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 783.4172 | 6.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 783.5706 | 5.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 783.6051 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5091 | 20.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5102 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5768 | 16.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5789 | 5.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5797 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5801 | 6.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5809 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5817 | 6.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5821 | 5.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5826 | 6.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5827 | 5.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5830 | 24.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5839 | 2.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5840 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5840 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5842 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5844 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5845 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5847 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5848 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.5848 | 5.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.6212 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.6232 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 784.8964 | 7.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.2296 | 0.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.2311 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.3936 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.5166 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.5825 | 6.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.5836 | 5.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.6510 | 5.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.6517 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.6524 | 5.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 785.6525 | 5.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.2334 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.2417 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5059 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5211 | 20.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5226 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5233 | 4.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5262 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5313 | 19.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5342 | 24.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5545 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5985 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5989 | 7.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5994 | 3.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5994 | 6.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5996 | 24.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.5999 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6000 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6001 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6001 | 6.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6001 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6003 | 24.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6004 | 4.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6004 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6004 | 8.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6004 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6005 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6005 | 20.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6005 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6006 | 2.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6006 | 4.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6006 | 4.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6008 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6010 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6042 | 7.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6463 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6470 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6470 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6471 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6471 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6479 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.6668 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7164 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7175 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7177 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7178 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7178 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7179 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7179 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7185 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.7654 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 786.8448 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.5260 | 19.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.5279 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.5412 | 19.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.5557 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.6029 | 8.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.6031 | 5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.6033 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.6043 | 8.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.6671 | 21.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.6681 | 24.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.8369 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 787.8413 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5187 | 3.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5197 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5201 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5385 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5419 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5430 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5430 | 5.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5442 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5461 | 20.66 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5470 | 4.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5479 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5492 | 24.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5494 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.5517 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6117 | 5.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6120 | 7.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6128 | 7.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6136 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6138 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6141 | 7.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6143 | 4.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6143 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6143 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6145 | 21.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6146 | 3.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6146 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6146 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6147 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6147 | 4.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6154 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6155 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6155 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6155 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6156 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6160 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6161 | 2.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6201 | 15.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6495 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6563 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6602 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6603 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6615 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6786 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.6854 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.7312 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.7321 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.7321 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.7323 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.7325 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.7325 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 788.7326 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 789.0788 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 789.5470 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 789.5507 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 789.6167 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 789.6175 | 5.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 789.6180 | 4.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 789.6182 | 24.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 789.6183 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.0873 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5316 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5346 | 2.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5349 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5367 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5369 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5385 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5424 | 19.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5481 | 20.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5483 | 20.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5540 | 15.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5547 | 14.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5556 | 5.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5567 | 5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5571 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5574 | 5.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5580 | 15.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5580 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5583 | 4.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5585 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5586 | 5.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5588 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5590 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5591 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5592 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5597 | 5.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5603 | 5.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5614 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5621 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5667 | 4.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5689 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 790.5700 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 791.4213 | 6.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 791.5625 | 24.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 791.6238 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.4261 | 6.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.4923 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5476 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5477 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5495 | 19.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5522 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5527 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5531 | 21.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5532 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5535 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5538 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5540 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5544 | 1.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5634 | 22.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5896 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5979 | 19.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.5992 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.6048 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 792.6720 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 793.5555 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 793.5570 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 793.5589 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 793.5622 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.4915 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.4973 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5090 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5648 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5654 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5657 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5666 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5669 | 2.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5669 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5670 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5671 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5672 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5672 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5676 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5678 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5678 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5680 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5687 | 4.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5690 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5702 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5705 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5796 | 19.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5824 | 21.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5851 | 19.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5895 | 20.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5909 | 20.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5950 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5965 | 22.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5976 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.5999 | 2.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.6035 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.6037 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.6042 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.6044 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.6044 | 4.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.6050 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 794.7210 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.3349 | 13.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.3350 | 13.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.3352 | 12.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.3356 | 12.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.3358 | 13.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.5687 | 3.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.5750 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.5761 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.5761 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.5761 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.5763 | 21.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 795.5795 | 20.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5216 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5217 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5239 | 6.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5255 | 5.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5753 | 3.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5766 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5786 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5797 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5802 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5803 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5824 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5827 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5829 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5831 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5832 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5838 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5843 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.5884 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.6124 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.6189 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.6193 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.6195 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.6196 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 796.6197 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5349 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5390 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5391 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5391 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5394 | 2.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5394 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5394 | 6.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5402 | 5.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5413 | 5.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5426 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5973 | 3.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5989 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.5997 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.6002 | 4.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.6004 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.6008 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.6015 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 798.6163 | 20.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 799.5375 | 2.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 799.5435 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 799.5452 | 1.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 799.7308 | 1.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.4274 | 5.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6106 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6137 | 21.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6148 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6149 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6151 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6152 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6152 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6152 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6164 | 4.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6176 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 800.6500 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 801.6175 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.4158 | 6.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.4183 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.4249 | 5.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.5314 | 20.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.5336 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.5345 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.5362 | 20.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.5364 | 20.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.6275 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.6283 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 802.6312 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 803.2298 | 7.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 803.5413 | 21.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 803.5429 | 22.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 803.5432 | 23.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 803.5432 | 23.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 803.5445 | 22.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5507 | 21.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5507 | 21.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5512 | 21.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5517 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5518 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5520 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5521 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5521 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5522 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 804.5886 | 2.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 805.5555 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5646 | 0.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5659 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5664 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5665 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5665 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5669 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5670 | 5.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5671 | 20.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5673 | 5.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5674 | 2.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5676 | 20.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5678 | 5.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5678 | 21.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5682 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5684 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5684 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5689 | 5.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5696 | 5.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5698 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.5705 | 5.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.6072 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.6079 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 806.6087 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 807.0709 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 807.5710 | 5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 807.5736 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 807.5756 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 807.6110 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5035 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5072 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5184 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5222 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5813 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5817 | 6.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5819 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5822 | 5.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5823 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5824 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5826 | 20.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5827 | 6.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5829 | 21.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5830 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5831 | 6.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5832 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5834 | 5.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5834 | 5.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5838 | 2.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5839 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5845 | 3.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5847 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5848 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5849 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5850 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5852 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5853 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.5876 | 6.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.6187 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.6266 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.6280 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.6282 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7020 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7020 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7025 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7031 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7034 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7475 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7493 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7500 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 808.7500 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 809.5828 | 6.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 809.5856 | 5.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 809.5859 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 809.5865 | 5.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 809.5867 | 5.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 809.5871 | 6.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 809.5907 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 809.5913 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.0928 | 21.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.2832 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.4186 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.4216 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5006 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5321 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5384 | 20.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5527 | 27.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5533 | 26.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5567 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5586 | 27.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5873 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5886 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5951 | 21.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5972 | 6.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5972 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5973 | 6.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5978 | 5.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5986 | 4.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5987 | 4.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5987 | 4.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5989 | 21.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5991 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5992 | 6.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5996 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.5997 | 6.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6000 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6001 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6002 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6003 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6005 | 6.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6015 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6019 | 6.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6438 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6439 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6444 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6455 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6465 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.6830 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.7182 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.7185 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.7187 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.7187 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.7189 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.7551 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.7564 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.7684 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 810.9211 | 5.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.5208 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.5500 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.5984 | 6.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.6010 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.6022 | 4.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.6673 | 5.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.6674 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.6675 | 5.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.6675 | 5.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 811.6693 | 5.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5147 | 3.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5172 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5176 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5179 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5180 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5186 | 3.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5386 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5394 | 5.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.5421 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6058 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6081 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6086 | 24.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6103 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6107 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6109 | 5.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6117 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6119 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6121 | 4.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6125 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6125 | 20.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6131 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6135 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6138 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6139 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6140 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6142 | 3.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6144 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6145 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6149 | 5.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 812.6151 | 4.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.5142 | 3.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.5206 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.5477 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.5489 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.6150 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.6820 | 24.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.6833 | 5.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.6838 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.6840 | 5.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.6841 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.6849 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 813.6861 | 24.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.4436 | 6.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5336 | 3.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5342 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5345 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5346 | 2.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5356 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5361 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5454 | 21.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5516 | 20.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5574 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.5654 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6264 | 2.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6279 | 20.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6284 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6293 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6295 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6299 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6299 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6299 | 4.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6299 | 4.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6301 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6303 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6303 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6304 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6305 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6305 | 4.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6307 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6343 | 20.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6778 | 19.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 814.6860 | 19.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 815.5076 | 19.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 815.5141 | 19.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 815.5355 | 2.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 815.6330 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 815.6962 | 4.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 815.6965 | 24.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 815.6970 | 21.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.5472 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.5480 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.5481 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.5487 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.5488 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.5558 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.5862 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.5871 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.6414 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.6417 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.6417 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.6419 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.6427 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 816.6436 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 817.6464 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.5649 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.5667 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.5676 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.5706 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.5712 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.5916 | 20.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.6013 | 21.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.6034 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.6039 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 818.6071 | 3.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 819.5750 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.0817 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.4136 | 7.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5087 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5116 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5219 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5824 | 3.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5831 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5835 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5839 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5841 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.5854 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.6045 | 20.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.6158 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.6193 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.6197 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.6198 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.6200 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.6203 | 24.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.6211 | 3.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.7382 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 820.7401 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 821.7391 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.5228 | 5.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.5232 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.5952 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.5978 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.5994 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.5994 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.5996 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.5999 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.6003 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.6011 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.6323 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.6324 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 822.7494 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 823.2702 | 6.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 823.4314 | 6.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 823.4347 | 6.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 823.6003 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 823.6009 | 6.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 823.7681 | 6.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 823.7687 | 6.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 824.5525 | 5.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 824.5539 | 6.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 824.5558 | 5.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 824.5559 | 5.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 824.6466 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 824.6480 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 824.6494 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 824.6959 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 825.5425 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 826.5354 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 826.5356 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 826.9375 | 6.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.7592 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.7596 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.7603 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.9268 | 6.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.9270 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.9274 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.9279 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.9285 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.9299 | 6.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 827.9381 | 6.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.0901 | 6.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.0946 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.0951 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.0961 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.0962 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.0963 | 6.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.1781 | 5.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.2619 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.2625 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.2627 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.2638 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.2673 | 6.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.4306 | 6.43 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.5482 | 21.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.5490 | 21.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.5501 | 20.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.5502 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.5508 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 828.5508 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 829.5438 | 21.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 829.5547 | 21.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5649 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5650 | 20.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5653 | 21.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5663 | 21.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5667 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5667 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5668 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5670 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5672 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.5932 | 5.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.7620 | 5.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.7633 | 5.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.9083 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 830.9271 | 5.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 831.5711 | 19.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.2406 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.2409 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.2410 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.2411 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5798 | 5.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5818 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5824 | 20.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5827 | 5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5828 | 5.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5835 | 5.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5837 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5837 | 4.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5841 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5849 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5851 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.5852 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.6270 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.6294 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.6301 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.6632 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 832.7056 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.2403 | 1.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.2567 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.4253 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.4259 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5052 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5940 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5947 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5950 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5962 | 5.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5972 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5984 | 4.81 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5986 | 2.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5990 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5991 | 3.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5991 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.5991 | 4.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6000 | 5.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6001 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6002 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6005 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6007 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6010 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6432 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6437 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6440 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6456 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.6796 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.7195 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.7209 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.7616 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.7634 | 5.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 834.9293 | 6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 835.6014 | 4.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 835.6651 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 835.6652 | 5.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 835.6654 | 5.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 835.6662 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 835.6662 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5355 | 5.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5403 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5417 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5426 | 24.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5427 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5427 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5427 | 5.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5429 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5430 | 4.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5431 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5432 | 4.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5432 | 4.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5433 | 4.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5434 | 4.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.5434 | 5.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6052 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6110 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6123 | 20.78 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6131 | 4.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6131 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6135 | 4.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6136 | 3.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6144 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6146 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6147 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6148 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6492 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6540 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 836.6551 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 837.5464 | 24.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 837.9373 | 6.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.5526 | 4.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.5558 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.5565 | 4.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.5567 | 4.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.5567 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.5568 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.5569 | 4.9 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.5575 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.6284 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.6288 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.6290 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.6290 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.7110 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.8391 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.8392 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.8393 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.8399 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.8405 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.8405 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.8409 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 838.8434 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 839.6323 | 4.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 840.5696 | 4.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 840.6424 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 840.6430 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 840.6437 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 841.5059 | 3.79 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 841.5062 | 3.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 842.5999 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 842.6596 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 842.6598 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 842.6605 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 842.6607 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 842.6613 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 843.5129 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 844.6354 | 2.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 844.6379 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 844.6729 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 846.2922 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 846.5990 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 846.7534 | 1.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.2719 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.5379 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.5384 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.5399 | 20.76 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.6309 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.6501 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.6503 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.7668 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.7683 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.7683 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.7691 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.7703 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 848.7731 | 1.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 849.7766 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.5515 | 5.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.5520 | 5.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.5532 | 20.74 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.5532 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.5535 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.5536 | 20.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.5536 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.5539 | 20.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.6618 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.6642 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.6663 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 850.7115 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 851.4005 | 13.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 852.4948 | 20.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 852.5514 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 852.6805 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 852.6811 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 852.6817 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 852.6841 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 852.7263 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 852.7269 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 853.7266 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5643 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5660 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5663 | 20.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5665 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5667 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5669 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5674 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5681 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5700 | 4.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 854.5814 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 855.5697 | 21.24 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 855.5703 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 855.5723 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 855.8271 | 24.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5031 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5054 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5091 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5788 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5800 | 20.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5800 | 21.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5809 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5810 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5813 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5819 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5819 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5824 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5826 | 3.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 856.5828 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 857.1743 | 7.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 857.2753 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 857.4762 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 857.6822 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 858.5165 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 858.5172 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 858.5221 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 858.5265 | 24.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 858.5972 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 858.5975 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 859.2516 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 859.5257 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 860.6061 | 21.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 860.6077 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 860.6136 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 860.6148 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 860.6149 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 860.6150 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 860.6151 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 860.6155 | 3.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 862.2445 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 862.4717 | 6.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 862.6230 | 1.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 862.6294 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 862.6296 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 862.6296 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 862.6297 | 4.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 862.6298 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.5625 | 3.05 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.5627 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.5631 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.5631 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.5640 | 2.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.6887 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.6895 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.6896 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.6899 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 863.6900 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 864.6433 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 864.6443 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 864.6444 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 864.6448 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 864.6450 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 864.7075 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 864.7113 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 865.4966 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 865.5740 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 865.5758 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 865.5778 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 866.6599 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 866.6600 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 866.6602 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 866.6604 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 867.5116 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 867.5179 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 868.1682 | 7.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 868.1689 | 7.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 868.1694 | 7.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 868.1705 | 7.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 868.6750 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 868.6753 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 868.6770 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 868.7386 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 869.5283 | 1.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 870.5287 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 870.6916 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 870.6918 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 870.6921 | 4.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 870.6928 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 870.7502 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 871.4642 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 872.4597 | 5.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 872.5364 | 20.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 872.7656 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 872.7694 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 872.8346 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 872.8355 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 872.8367 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 872.8377 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 874.5507 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 874.5559 | 24.6 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 874.7842 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 874.7872 | 1.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 875.7852 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 875.7895 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.5648 | 21.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.5648 | 21.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.5679 | 5.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.5687 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.5703 | 21.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.6804 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.6818 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.6829 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.7975 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.7977 | 1.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.7989 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.7996 | 1.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.7998 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.7999 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.8009 | 1.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 876.8018 | 1.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 877.7983 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 878.5674 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 878.5675 | 4.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 878.5823 | 21.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 878.5835 | 20.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 878.5852 | 21.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 878.6925 | 4.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 878.6976 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 879.5850 | 21.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 879.7410 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.5006 | 24.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.5815 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.5827 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.5827 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.5843 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.5843 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.5871 | 24.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.5898 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.7125 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.7149 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.7171 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 880.8360 | 24.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 881.7561 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 882.5974 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 882.5976 | 4.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 882.5977 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 882.5977 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 883.0907 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 883.2892 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 883.4868 | 7.04 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 883.5987 | 4.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 884.1870 | 1.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 884.6056 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 884.6061 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 884.6064 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 884.6108 | 4.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 884.6118 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 884.6119 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 884.6122 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5391 | 24.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5443 | 3.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5461 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5463 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5464 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5469 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5471 | 2.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5472 | 3.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5473 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.5485 | 3.5 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.6702 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.6717 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.6724 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.6729 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 885.6745 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 886.5501 | 2.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 886.6277 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 886.6285 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 887.5598 | 24.58 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 887.5621 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 887.5626 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 887.5629 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 887.5629 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 887.5636 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 888.5702 | 2.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 888.6444 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 888.6448 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 888.6455 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 889.4981 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 889.4990 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 889.5758 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 889.5763 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 889.5766 | 3.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 889.5769 | 2.73 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 889.6500 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 890.1496 | 7.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 890.5086 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 890.5146 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 890.5797 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 890.6594 | 4.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 890.6612 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 890.6637 | 4.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 892.6767 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 892.6771 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 892.6777 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 894.6896 | 4.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 894.6929 | 4.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 894.6929 | 4.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 894.6934 | 4.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 894.7539 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 894.7548 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 896.5384 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 896.7650 | 1.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 897.2269 | 10.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 898.6082 | 1.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 898.7805 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 898.7832 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 898.7833 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 898.7835 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 898.7839 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 900.5694 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 900.5696 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 900.7980 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 900.7989 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 900.7989 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 901.8051 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 902.8141 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 902.8142 | 1.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 902.8144 | 1.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 902.8153 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 902.8155 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 903.7360 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 903.7410 | 0.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 903.8242 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 904.5886 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 904.5898 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 904.5936 | 2.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 904.5967 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 904.8260 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.2586 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.2586 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.2590 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.2608 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8262 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8266 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8269 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8270 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8274 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8276 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8292 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8305 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8311 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 906.8317 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 907.5275 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 907.5284 | 2.97 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 907.5290 | 2.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 907.5290 | 2.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 907.5293 | 2.8 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 907.5296 | 2.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 907.5303 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 907.5310 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 909.5425 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 909.5431 | 24.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 909.5450 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 909.5454 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 909.5455 | 2.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 909.5456 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 909.5463 | 3.29 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 909.5471 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 911.4781 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 911.4819 | 1.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 911.5587 | 2.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 911.5602 | 2.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 911.5604 | 2.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 911.5628 | 2.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 913.5751 | 2.87 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 913.5754 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 913.5757 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 913.5757 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 913.5763 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 914.5769 | 2.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 915.5865 | 2.85 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 915.5892 | 2.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 915.5953 | 2.75 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 916.5295 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 916.6801 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 918.5379 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 918.5383 | 24.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 918.5425 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 918.6935 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 918.6936 | 4.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 920.3091 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 920.7690 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 920.7691 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 921.3086 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 922.2863 | 0.84 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 922.5519 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 922.7825 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 922.7844 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 922.7860 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 924.5679 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 924.7947 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 924.7966 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 924.7985 | 1.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 926.8122 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 926.8134 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 927.7422 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 929.5617 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 929.6897 | 1.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 931.5250 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 931.5254 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 931.5264 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 931.5270 | 2.82 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 931.5274 | 2.92 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 931.5275 | 2.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 931.5296 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 933.5392 | 2.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 933.5417 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 933.5422 | 2.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 933.5430 | 2.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 935.5601 | 2.7 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 936.7484 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 936.7494 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 940.8222 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 940.8238 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 940.8250 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 940.8251 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 941.6995 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 942.4997 | 6.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 944.5550 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 944.5573 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 944.5584 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 946.5750 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 948.7894 | 1.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 948.7984 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 948.7993 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 948.8003 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 948.8014 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 950.3316 | 9.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 950.4105 | 9.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 950.8080 | 9.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 950.8116 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 950.8127 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 950.8127 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 950.8149 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 950.8160 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 952.3071 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 952.4173 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 952.5270 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 952.6393 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 952.7512 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 952.8280 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 952.8615 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 952.9722 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 955.1550 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 955.5776 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 956.1384 | 1.72 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 957.5443 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 959.6088 | 17.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 959.6093 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 959.6095 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 959.6105 | 16.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 959.6113 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 971.8328 | 10.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 972.0796 | 10.65 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 972.7991 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 972.7995 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8142 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8144 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8152 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8152 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8153 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8154 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8157 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8159 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8183 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8184 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 974.8197 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 975.3834 | 7.83 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 975.3849 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 975.3850 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 975.3850 | 7.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 975.3852 | 5.1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 975.3852 | 7.27 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 975.3859 | 4.28 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 978.7588 | 1.01 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 979.5789 | 15.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 983.6047 | 17.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 983.6089 | 17.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 983.6099 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 991.3315 | 8.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 991.6739 | 16.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 991.6741 | 17.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 992.7386 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 992.7388 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.1124 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.3110 | 6.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.3124 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.3134 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.3157 | 5.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.5114 | 5.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.5116 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.5138 | 5.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.5153 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.7121 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.7127 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.7136 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.7144 | 5.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.9071 | 5.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.9100 | 6.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 993.9112 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 994.1128 | 5.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 994.3248 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 995.5252 | 6.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 996.7247 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 996.7993 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 997.3641 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 997.3654 | 7.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 997.3668 | 7.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 997.3671 | 7.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 997.3676 | 7.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 997.6950 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 997.6960 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 998.8155 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 999.5142 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 999.5438 | 14.19 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 999.5456 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 999.5477 | 15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1000.7843 | 0.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1000.7894 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1003.5762 | 16.31 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1003.5766 | 15.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1003.5776 | 15.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1003.5779 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1003.5781 | 16.17 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1003.5783 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1003.5794 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1003.5817 | 15.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1006.7197 | 0.91 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1006.7208 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1008.8113 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1008.8122 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1008.8131 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1008.8133 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1012.1656 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1012.1657 | 1.71 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1013.5317 | 6.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1027.5751 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1027.5759 | 15.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1027.5761 | 15.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1027.5778 | 15.08 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1027.5779 | 16.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1027.5780 | 15.15 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1027.5793 | 16.02 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1027.5798 | 16.3 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1029.4470 | 9.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1029.5316 | 9.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.1918 | 2.26 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8018 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8023 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8024 | 24.16 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8033 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8033 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8035 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8066 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8066 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8067 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1042.8073 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1043.1841 | 2.03 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1043.7031 | 16.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1043.7043 | 16.77 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1043.7059 | 17.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1045.6244 | 16.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1051.5780 | 15.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1051.5781 | 16.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1051.5789 | 15.99 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1055.6103 | 16.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1055.6110 | 16.64 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1055.6111 | 15.62 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1065.6897 | 17.36 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1066.6515 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1066.6522 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1066.6524 | 0.95 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1066.6539 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1066.6573 | 0.98 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1069.6273 | 16.07 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1071.2179 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1071.3430 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1071.4693 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1071.5938 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1071.6075 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1071.6085 | 1 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1071.7201 | 7.96 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1071.8443 | 7.93 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1075.7167 | 23.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1076.7947 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1076.7980 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1076.7993 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1076.8001 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1076.8006 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1084.5825 | 6.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1087.6729 | 16.12 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7898 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7906 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7906 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7912 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7917 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7924 | 24.14 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7926 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7947 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7954 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1110.7959 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1111.5448 | 8.67 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1122.9422 | 9.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1123.4824 | 9.38 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1128.2531 | 7.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1134.3268 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1144.7863 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1144.7884 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1144.7894 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1144.7898 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1147.3305 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1147.3305 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1147.3340 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1147.3375 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1147.8391 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1150.2248 | 7.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1150.2364 | 7.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1159.8389 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1160.3370 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1161.3505 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1161.3511 | 24.09 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1161.3551 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1172.3411 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1172.3493 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1172.8459 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1173.8533 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1173.8537 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1174.3602 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1174.3618 | 24.13 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7780 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7790 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7797 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7797 | 24.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7801 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7805 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7823 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7829 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1178.7829 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1185.3480 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1185.3515 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1187.8644 | 24.11 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1188.8684 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1190.3733 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1194.8143 | 1.06 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1194.8175 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1194.8183 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1196.8547 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1198.3542 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1198.8554 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1199.8337 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1199.8419 | 0.86 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1199.8670 | 24.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1202.3767 | 24.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1203.3963 | 24.46 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1211.3638 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1212.3708 | 24.41 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1212.7768 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1212.7768 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1212.7774 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1212.7779 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1224.3909 | 7.94 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1233.8389 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1235.1405 | 9.33 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1235.2349 | 9.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1235.5441 | 9.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1246.7649 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1246.7660 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1246.7675 | 24.32 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1246.7689 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1246.7705 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1246.7724 | 24.48 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1246.7727 | 24.23 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1259.8534 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1261.8660 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1261.8670 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1261.8705 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1280.7634 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1280.7660 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1280.7663 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1280.7694 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1285.8675 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1287.8825 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1287.8838 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1287.8855 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1289.8972 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1309.8691 | 4.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1311.8848 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1314.7523 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1314.7562 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1314.7577 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1314.7578 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1314.7595 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1314.7609 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1335.8852 | 4.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1342.9243 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1342.9259 | 0.88 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1342.9259 | 0.89 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1348.7517 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1348.7518 | 24.55 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1348.7528 | 24.18 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1348.7531 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1372.5914 | 9.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1382.7463 | 24.53 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1382.7475 | 24.25 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1382.7476 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1382.7478 | 24.21 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1382.7494 | 24.37 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1416.7364 | 24.35 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1416.7420 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1416.7434 | 24.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1417.2424 | 24.22 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1436.0673 | 4.69 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1438.0827 | 4.68 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1450.7338 | 24.34 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1450.7343 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1464.0972 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1464.0992 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1464.0994 | 4.54 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1464.1000 | 4.59 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1467.1131 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1484.7225 | 24.2 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1490.1123 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1490.1148 | 4.63 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1490.1153 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1490.1213 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1491.1190 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1491.1194 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1491.1214 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1492.1286 | 4.61 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1492.1289 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1492.1293 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1492.1294 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1492.1298 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1517.1394 | 4.57 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1518.1451 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1518.1458 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1518.1461 | 4.56 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1519.1502 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1520.1581 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1520.1583 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1520.1600 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1544.1541 | 4.39 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1544.1612 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1544.1612 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1544.1620 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1544.1623 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1545.1639 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1545.1640 | 4.42 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1546.1743 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1546.1755 | 4.51 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1546.1757 | 4.52 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1546.1759 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1549.1950 | 4.47 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1569.1682 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1571.1836 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1572.1881 | 4.49 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1572.1890 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1572.1908 | 4.44 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1572.1940 | 4.4 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells | |
| AN001687 | 1575.2068 | 4.45 | Minutes | ST001029 | POSITIVE | Waters Synapt G2 | Reversed phase | Human | Leukemia cells |
